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Background:  Drug policies in western countries, as well as countries in most other 
parts of the world, support self-medication with Over-The-Counter (OTC) drugs. The 
switch from prescription (Rx)-to-OTC has been most common in the Nordic countries, 
Great Britain and Germany in the last decades and deregulations were done to make it 
possible to sell OTC analgesics other places than under the pharmacy monopoly. 
Individual registration of OTC drugs cannot be done and therefore it is important to do 
public surveys to get information on consumption patterns of those drugs. The aim of 
the study is to describe where the different OTC analgesics are bought and how they are 
used in the population, and to assess whether or not recommended guidelines are 
followed.  
Material and method: A cross-sectional study was conducted based on data from the sixth 
survey of the Tromsø study, Tromsø 6, in 2007-2008. The data included information from 
questionnaires and physical examinations of the 30-89 years study population (n=12981).  
A specific questionnaire was given, on OTC analgesic use within the last four weeks before 
the interview, for the users of OTC analgesics.  
The wholesaler-based drug statistics from Norwegian Institute of Public Health (NIPH) 
was used to compare the consumption of OTC analgesics over time and to get ideas 
about changes in use since OTC analgesics became available outside pharmacy, in 
grocery shops and petrol stations etc. in 2003. 
Results: There was a 45.3 % prevalence of OTC analgesic use within last 4 weeks before 
the interview (54.9 % women and 33.6 % men). Most of the OTC analgesics were used 
seldom (less than every week) by 73.5 % of users, and in a small daily dose, (1-2 tablets) 
by 78.4 %.  
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There was 70.0 percent women and 60.5 percent men who bought OTC analgesics from 
the pharmacies only, while 6.3 percent women and 15.8 percent men bought OTC 
analgesics from non-pharmacy outlets only.  
The total sales (OTC+Rx) of paracetamol, ibuprofen, naproxen, diclofenac, ASA and 
phenazone-caffeine, in Defined Daily Dose/1000 inhabitants/day, increased by 40 %, 
from the year 2003 to 2016 according to statistics from Norwegian Institute of Public 
Health (NIPH). The prescription of those medicines doubled from 2003 to 2016. The 
OTC sales on the other hand went down by 4.5 %.  
Conclusions: The majority of the adult OTC analgesic users in the present study follow 
the guidelines for use of OTC analgesics. Most of the OTC analgesics were used seldom 
and in a small daily dose. A small number of the participants report adverse effect from 
OTC analgesics. It is headache, muscle and joint pain and backache that is the main 
reasons for using OTC analgesics. The majority of the OTC analgesic users, use to buy 
there OTC analgesics at the pharmacy.  
 
Key words: Population study, Public Health, Pharmacoepidemiology, Non-prescription 
analgesics, Self-medication, OTC analgesics, OTC drugs, Pain, Norway  
vii 
 
List of abbreviations 
ADEs  Adverse Drug Events 
ATC   Anatomical Therapeutic Chemical Classification 
ASA   Acetylsalicylic acid  
BMI  Body Mass Index 
CI  Confidential Interval 
DDD    Defined Daily Dose 
GI  Gastro Intestinal 
GP  General Practitioner (fastlege) 
LUA  “Legemidler Utenom Apotek” Sales of OTC drugs outside pharmacies 
NSAID  Non-steroidal Anti-Inflammatory Drugs. 
NIPH  Norwegian Institute of Public Health (Folkhelseinstituttet) 
OR  Odds Ratio 
OTC   Over-The-Counter (medicine sold without prescription) 
POM      Prescription only medicines 
Rx  Prescription (medicine sold with prescription) 
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1.1 The importance of the study and reasons for use of OTC analgesic 
1.1.1 The importance of doing population studies on use of non-prescription OTC 
analgesics. 
Drug policies in western countries, as well as countries in most other parts of the world, 
support self-medication with Over-The-Counter (OTC) drugs.  According to European 
Union Directive 92/96, “a drug should be sold without a prescription unless its use 
without medical supervision is dangerous, it is frequently used incorrect, it is a new 
chemical entity or it is administrated parenterally”. Of the European countries, 
prescription (Rx)-to-OTC switches has been most common in the Nordic countries, Great 
Britain and Germany during the 1980s and early 1990s. In most European countries OTC 
drugs are sold in pharmacies only [1]. 
It is important to do public surveys that can give us information on consumption patterns 
of OTC drugs. It is a suitable way to do such studies to get information about the pattern 
of utilization. Through health surveys, the population are asked about drug use patterns 
and it is possible to study if the patterns differ among people with different living 
conditions, socioeconomic status, age, gender, education, pain conditions or intensity, and 
lifestyle choices. OTC drugs are by definition not prescribed by a physician and the use by 
individuals are therefore not registered. By such a survey, we can explore how these 
drugs are used, the preferential drug of choice, frequency of use, concomitant of overuse, 
purpose of use and side effects. We can also gather information about buying habits and if 




1.1.2 Reasons for use of OTC analgesics according to other studies 
Pain and pain-related disease obviously represent the most common reason for analgesic 
use. Headache, ache in shoulders, joints and muscles, backache are treated with OTC 
analgesics as well as cold or flu symptoms [2,3,4].  There is, however, reason to believe 
that factors other than pain are important in the use of these drugs. Studies show that 
analgesics are more often used by women [2,3,4,5]. Overweight women have a higher 
total use of prescription medicines than other women do[6]. Health status is very 
important for drug use in general and for analgesic use in particular. Physical function 
and lifestyle are closely related to health status, and it has been suggested that physical 
functioning is also related to analgesic drug use. Analgesic use has also been found related 
to mental health. Psychological symptoms such as depression, insomnia and anxiety have 
been significantly related to analgesic use in some studies [2,3,7,8].  
1.1.3 What other studies reports about OTC analgesic frequency use 
To compare the prevalence of OTC analgesic use and the share of OTC users in the 
different studies is difficult because it is measured in different length of time. In the 
Tromsø study 2007-2008 there were 60% women and 37% men using analgesics in the 
last four weeks [9]. Another Norwegian study (HUNT 3) 2006-08, reported 47% 
prevalence of OTC analgesic use among men and women at least once per week in the last 
month [10]. In a computer aided telephone survey, in Australia in 2009, there was 55% 
prevalence use at least once per month among those who have reported ever using an 
OTC analgesic [11]. In a study in Scotland, a postal survey in 2002, 37% reported OTC 
analgesic use within the last two weeks [4]. From a recent, randomly selected population 
study (web), in Sweden (2013), they reported 47% OTC analgesic users with use of 
analgesics at least monthly or more in the 6 months prior to the study [12].  
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1.1.4 Characteristics of OTC analgesic users according to other studies 
Women use more OTC analgesic than men do. In the Tromsø Study 1986-87 there was 
more than double use of analgesic among women [3], in Sweden 1988/89 it was more 
than 50% higher use for women [2]. In Scotland 2002 the prevalence of women was 
higher compared to men OR 1.70 (CI 95% 1.33-2.18) [4]. In a German survey from 2011, 
the women had higher prevalence of analgesic drug use than men OR=1.58 (CI 95%1.35-
1.85)  [5]. In an Australian study from 2009, regular users of analgesics were more likely 
to be female (57%, n=1297/2276) [11]. In the HUNT3 population 2006-2008, there was 
33% higher use of OTC analgesic among women compared to men [10], and in Tromsø 
2007-08, there was 62% higher total analgesic use among women compared to men [13]. 
Younger people use more OTC analgesic than older people do. Porteous et al 
reported in 2005 an unadjusted OR=2.70 (CI 95% 2.11-3.46) and multi-adjusted OR=1,52 
(CI 95% 1.05-2.20) of OTC analgesic use in the group of people under 60 years, compared 
to those 60 years and above [4]. Sarganas et al reports in 2015 that Use of OTC analgesics 
is lower among older adults (65-79 years) OR=0.31 (CI 95% 0.22-0.44) compared to all 
other groups [5]. Stocik et al. reported in 2011 that “More people under the age 54 years 
reported regular use of OTC analgesics than did those aged 55 years or more” [11]. 
Håkonsen et al. reported in 2016 “participants in the age range 20-39 years reported more 
frequent use of OTC drugs compared with the other age groups” [12]. Dale et al reported 
from the HUNT3 study that OTC paracetamol is used almost at the same level in all age 
groups, but ASA is used more among those who are older than 60 years and NSAID is used 
more among those who are younger than 60 years [10]. 
People with self-reported bad health use more OTC analgesic than those with good 
health. Self-perceived health explained much of analgesic use in the Swedish study 
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(1988-89) OR=1.56 (CI 95%1.30-1.87) for men and OR=1.42 (CI 95% 1.20-1.69) for 
women [2]. Porteous et al. reported from a Scottish study that those with “good or very 
good” or “fair or poor” were twice as likely to use non-prescription analgesics as those 
reporting “excellent” health [4].  This finding has been confirmed in another study. [9]. 
1.2. Background, Terminology and Explanations 
1.2.1 Pain 
IASP (International Association for the Study of Pain) has defined pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage or 
described in terms of such damage” [14].  
“Pain is a personal experience that cannot be detected or ruled out by objective methods. It 
is therefore meaningless to question a patient's pain experience. Pain may occur without 
being possible to detect any tissue damage”. “It is important to distinguish between acute 
and persistent pain. In case of acute pain, it is often easier to determine a likely pain cause 
and prescribe effective treatment.”” The persistent pain is usually multifactorial and in many 
cases means a therapeutic challenge” [15,pp 889-890]. 
“Injury does not only produce pain, it also leads to stress, which the body attempts to deal 
with by achieving homoeostasis. This process involves neural, hormonal, and behavioural 
activities derived from genetically determined repertoires. These homoeostatic repertoires 
exist at the injury site (cytokine release, for example), in the adrenal cortex (release of 
corticosteroids), the immune system, and in widely distributed areas in the brain” [16]. 
1.2.2 Analgesics 
Analgesics are among our most commonly used drugs[17,18]. They are used in the 
treatment of both acute and chronic pain. Analgesics, also called painkillers, are 
pharmaceuticals used to relief pain and can be divided into opioid and non-opioid 
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analgesics. Opioids acts on the central nervous system (CNS) as depressants and 
stimulants, often with a good effect on pain, but causes also addiction among other 
adverse effects.  That is the main reason to avoid them. The World Health Organisation 
(WHO) recommend a pain ladder[19] where the first step is to use non-opioids such as 
Paracetamol and/or non-steroidal anti-inflammatory drug (NSAID). At step two, you 
continue with week opioids such as codeine or tramadol in combination with non-opioids 
and then goes further on to a stronger opioid such as oxycodone, morphine or fentanyl 
also in combination with non-opioids until you receive pain relief. A good analgesic drug, 
should in a proper dose, relieve pain without giving side effects.  
1.2.3. Over-The-Counter (OTC) drugs  
Over-The-Counter (OTC) drugs represent the drugs that are sold without prescription in 
and outside pharmacies. People may also buy them on the internet or abroad.  
1.2.4 Sales of OTC drugs outside pharmacy/“Legemidler utenom apotek” (LUA)  
In Norway, some drugs were released for selling outside pharmacy in grocery shops, 
petrol station etc. in the year 2003. A new reform was established through political 
decision. The monopoly of the pharmacies was abolished and enabled supermarkets, 
grocery stores, convenience stores and petrol stations (non-pharmacy outlets), to sell 
some specific drugs i.e. analgesics, nicotine replacement medicines, nasal decongestants, 
expectorants, motion sickness tablets and antihistamine[20]. The reform is called LUA 
“Legemiddel utenom apotek”[21]. Emergency contraceptives, allergy medicine, 
hydrocortisone dermatological and agents used for treatment of dyspepsia, antacids, 
were included from January 2009 [22,p12]. 
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1.2.5 OTC analgesics sold in pharmacy and outside pharmacy  
The OTC analgesics available in Norway are paracetamol, acetylsalicylic acid (ASA), 
ibuprofen, naproxen, diclofenac (was not sold as OTC between 2005 and 2008) and 
phenazone in combination with caffeine.  There are limitations on which strength and size 
of package that are sold as OTC analgesic. The only analgesics sold outside pharmacy 
today are paracetamol and ibuprofen. Phenazone-caffeine was sold outside pharmacy 
until the 1 February 2011 [22,p.16]. Paracetamol is the most common sold analgesic not 
only in Norway but also worldwide. The NSAIDs, ibuprofen and naproxen are then the 
second and third most common sold OTC analgesics.  The sales of ASA as an analgesic is 
very low. It was much more common earlier, but because of its serious side effect, other 
analgesics has been promoted as the drug of choice[23]. Phenazone-caffeine is a product 
that has a long tradition in Norway only, and has been sold since 1930. England has no 
product with phenazone and phenazone preparations were withdrawn from the US 
market after a report from US Food and Drug administration (FDA) in the 1990s that 
stated that the drug was neither safe nor effective [24,p.8-9]. Phenazone has  not been 
promoted for years and the sales has declined considerably in Norway [24,p.17-22]. 
1.2.6 Defined Daily Dose (DDD) 
The use of DDDs as units of measurement offers better possibilities for comparisons 
between alternative medicinal products, independent of price differences. A DDD is 
defined as the assumed average maintenance dose per day for a drug used on its main 
indication in adults. The sales figures are given as the number of DDDs/1000 
inhabitants/day. Ten DDDs/1000 inhabitants/day corresponds to a daily use of this drug 
by 1% of the population. This estimate is, however, only valid if there is good correlation 
between the DDD and the actual consumed dose[22]. Despite of that, these figures will be 
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useful when we compare the use over time, and the use between different generic 
products. 
1.2.7 Anatomical Therapeutic Chemical Classification (ATC) 
In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances 
are divided into different groups according to the body organ or system on which they act 
and their therapeutic, pharmacological and chemical properties. Drugs are classified in 
groups at five levels.  The drugs are divided into 14 main groups (1st level), with 
pharmacological/therapeutic subgroups (2nd level).  The 3rd and 4th levels are 
chemical/pharmacological/therapeutic subgroups and the 5th level is the chemical 
substance[25]. Paracetamol, acetylsalicylic acid and phenazone caffeine are all classified 
under the ATC group, N-nervous system and its subgroup N02B other analgesics and 
antipyretics. Ibuprofen, naproxen and diclofenac are classified under ATC group M-
Musculo-skeletal system and its subgroup anti-inflammatory nonsteroid drugs.  
 1.2.8 Sales statistics: General trends concerning OTC analgesics 
The sales of analgesics has increased considerably in Norway over the last three decades. 
The sales of NSAIDs more than doubled, paracetamol tripled, while high-dose ASA 
declined substantially in Norway from 1990 to 2016 [26,pp 66-73]. The sales of OTC 




1.3 The OTC analgesics 
1.3.1 Paracetamol 
Paracetamol is safe and effective when used properly and can be used both by children 
and adults. It also acts as a fever depressant. Paracetamol is recommended as the first 
choice in the treatment of pain.  However, the number of inquiries into poison 
information board about paracetamol has increased [27,28,29]. Paracetamol is one of the 
most commonly used drugs in Norway. OTC sales correspond to almost two packs per 
person per year or on average 36 tablets in 2016 [26,p.12]. “The total sales of 
paracetamol, both OTC and Rx, measured in DDDs have increased gradually. OTC sales have 
been relatively stable since 2010.” “The sale of Rx paracetamol in large packages is the 
reason for the increase in total sales of paracetamol. Increased prescribing for use in chronic 
pain that are reimbursed has probably contributed to this” [30]. 
1.3.2 Nonsteroidal Anti-inflammatory Drugs (NSAID) 
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely prescribed because of their 
analgesic and anti-inflammatory properties. Their use is associated with the occurrence of 
serious adverse drug events (ADEs), particularly of the gastrointestinal, cardio-vascular, 
and renal tract. In general, short-term use of NSAIDs is considered relatively safe, 
provided it is used in OTC-doses by adults without contraindications or interacting 
medications[31]. OTC Ibuprofen is sold both in and outside pharmacies while OTC 
naproxen and OTC diclofenac are sold in pharmacy only (diclofenac was not sold as OTC 
in the year 2005-2007). 
1.3.3 Acetylsalicylic acid (ASA) 
ASA is an old analgesic and antipyretic drug that has been used a lot worldwide. 
Indications for OTC ASA in Norway are analgesic, antipyretic and anti-inflammatory use. 
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Because of its dangerous side effects with gastrointestinal bleedings and risk of other 
inner bleedings, guidelines from the health authority has recommended other analgesics 
than ASA for treatment of pain[32,pp.1237-1240].  
1.3.4 Phenazone with caffeine  
Phenazone is an analgesic and antipyretic drug. Phenazone caffeine has been sold both in 
and outside pharmacies from 2003-2011. Today it is sold in the pharmacies only [22]. 
1.4 Adverse effects of OTC analgesics 
OTC analgesics sold from non-pharmacy outlets, are advocated particularly to be safe and 
well tolerated. However, inappropriate use, abuse or concomitant use with other OTC 
drugs or prescribed drugs can lead to adverse effects. These adverse effects include upper 
gastrointestinal (GI) bleeding and perforation, renal failure, heart failure and damage on 
the liver [32,pp.1237+1292]. The decision to use any analgesic is a balance of benefit and 
risk. In the case of analgesics, it is important to balance the therapeutic benefit against 
both the risk in therapeutic use and the risk in overdose. Some analgesics have adverse 
effects in therapeutic doses; all analgesics are toxic in overdose[33] . 
1.4.1 Adverse effects of Paracetamol  
Paracetamol is recommended because of few side effects, when used for short time and in 
therapeutic doses, even though it might not be as effective as some NSAID products 
[34,p24], [35,p1061]. Paracetamol does not affect the thrombocyte aggregation and does 
not cause damage to the gastrointestinal mucous membrane as NSAID products does. It 
can give allergically reactions, leukopenia, thrombocytopenia and haemolytic anaemia. 
Use over long time can also give chronically headache. There are risk for liver and 
cardiovascular damages with prolonged use of large doses. Also in ordinary doses, it can 
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cause damages to patients with poor nutritional status and to patients with chronic 
alcohol abuse[32,p.1292]. Liver and kidney damage is a big risk associated with self-
injury and poisoning of paracetamol. Antidote treatment with acetyl cysteine will give 
complete protection of liver damage if started 8 hours after intake[36]. Potential risk of 
severe damage of vital organs are there and intensive treatment and care are required for 
several days. Liver transplantations can be a consequence if treatment do not start in 
time[33]. 
1.4.2 Adverse effect of NSAID and ASA 
NSAID and ASA has a wide spectrum of gastrointestinal side effects from dyspeptic 
symptoms to life threatening bleeding and perforation. Gastric and duodenal changes is 
frequently and most clinically important. Advanced age, previous ulcer disease, 
concomitant use of glucocorticoids increases the risk of gastrointestinal complications 
(severe ulcers, gastrointestinal bleeding, and perforation). “There is a correlation between 
dose of NSAIDs and the development of ulcer disease, and one should always strive to use the 
lowest possible effective dose for the shortest possible time”[35]. In patients with renal 
failure or severe heart failure, NSAID can lead to further reduction in renal function with 
renal blood flow and sodium retention. Worsening or provocation of hypertension have 
been reported, as well as heart failure. Caution is advised in patients with coronary artery 
disease. 2400 mg or more ibuprofen per day increases the risk of cardiovascular disease. 
Diclofenac is contraindicated in patients with coronary disease.  
Bronchoconstriction can be triggered or worsened in especially vulnerable patients 




1.4.3 Adverse effect of phenazone-caffeine 
Adverse effects are rare. Poisoning risk is probably small. There is a risk of anaphylactic 
reactions. It may cause headaches on withdrawal - "habituation headache"[32,p.1291]. 
Overdose may give nausea, vomiting, circulatory disorders, excitation, convulsions and 
coma[37,p.762] . Chronic use of large doses may cause risk of renal complications. 
Prolonged use creates the risk of allergic reactions, gastrointestinal and renal side effects. 
Caffeine doses of 1 g (10 times recommended dose) for adults can cause reactions of the 
central nervous system and circulatory disorders with tachycardia, extra systoles and 
increased respiratory rate. Nausea, headache, dizziness, agitation, tinnitus, tremor, 
excitation, tachypnea and increased urine output[38]. 
1.4.4 Abuse and overdose of OTC analgesics 
There are indications that some individuals use OTC analgesics to treat psychological 
problems and stress [7,8,39]. Overdose is also related to self-medication of OTC 
analgesics. Adverse drug reaction related to self-medication resulted more frequently in 
neurologic and psychiatric side effects compared to ADR caused by a medical 
prescription[40]. The principal factor in the frequency of paracetamol overdose is ease of 
access. Availability of paracetamol in large quantities contributes to its use in overdose. 
Limiting availability could prove an effective strategy for reducing the frequency of 





1.6 Aims and study questions  
1.6.1 Aims 
 
The aim of the project is to describe how the different OTC analgesics are bought and used 
in the population, to characterize the users of OTC analgesics and to assess whether or not 
recommended guidelines are followed.  
  
 
1.6.2 Study questions 
 Is self-medication of OTC analgesics in accordance with guidelines? 
 Do people experience adverse effects from OTC analgesics? 
 What kind of pain problems do people self-medicate with OTC analgesics? 
 How many purchase OTC analgesics on the internet and abroad, and are there 
differences in the user characteristics of people buying OTC analgesics in the pharmacy 
compared to non-pharmacy outlets, difference in regards to demographics, social 




2. The Tromsø study. Study population and design 
2.1 The Tromsø Study 
The Tromsø Study is a population-based, prospective study of various health issues, 
symptoms, and chronic diseases. Seven surveys have been carried out 6–7 years apart, 
referred to as Tromsø 1–7. The surveys have been carried out in the municipality of 
Tromsø, Northern Norway from 1974 to 2016 [44].  
The Tromsø Study was initiated in 1974 in an attempt to help combat the high mortality 
due to cardiovascular diseases in Norway.  
The primary aim of the Tromsø Study was to determine the reasons for the high mortality 
of cardiovascular disease, and to develop ways of preventing heart attacks and strokes. 
The study was gradually expanded to include many other chronic diseases and other 
problems such as rheumatism, neurological and mental diseases, skin diseases, stomach 
and bowel-related diseases, cancer and osteoporosis. 
In all, a total of more than 45 000 different people have participated in one or more of the 
seven surveys that are completed since 1974. 
The Tromsø Study cohort consists of people living in the municipality of Tromsø, Norway, 
situated at 69° N. In 2007-2008 when the sixth survey was conducted, Tromsø consisted 
of 70,000 inhabitants, about 60,000 people lived in the city area, while the rest was 
scattered throughout the whole municipality (2558 square kilometres). Tromsø is a 
centre of education, research, administration and fishing related activities. The population 
is growing and dominated by Caucasians of mainly Norwegian origin, but also includes a 
Sami minority. Tromsø may be considered as representative of a Northern European, 
white, urban population[44].  
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2.2 Study population and design 
Participants are from the sixth wave of the Tromsø study, Tromsø 6. Tromsø 6 was 
conducted in 2007–08 among men and women 30–87 years old living in the municipality 
of Tromsø. A total of 19,762 people were invited and 12,984 of them were examined 
(65.7%). A personal invitation, an information folder, and a four-page questionnaire Q1 
(Appendix 2), were posted to the participants about 2 weeks before the suggested 
appointments.  
All residents aged 40–42 and 60–87(n=12,578), a 10% random sample of individuals 
aged 30–39 (n=1056) and a 40% random sample of individuals aged 43–59 (n= 5787) 
were invited to the sixth wave of The Tromsø study.  
In addition study subjects who had attended the second visit of Tromsø 4, (included 
ultrasound examination of the carotid arteries, echocardiography, and bone scan), if not 
already included in the three groups above and still residing in Tromsø municipality 
September 2007, (n=341),  were also invited[44].  
 
2.3 Questionnaires 
In the first questionnaire Q1, participants were asked, “How often have you during the 
last four weeks used painkillers without prescription?”  Out of 12 693 of the participants 
(288 missing), 5 275 (41.6 %) answered that they had used OTC analgesics during the last 
four weeks. The participants of Tromsø 6 answered the second questionnaire (Q2), that 
was handed out to the participants and either returned at the study site or sent back by 
mail, and 12 440 participants (95.8%) answered Q2.  
Those participants that confirmed in Q1 that they had used OTC analgesics within last 
four weeks were asked to answer a specific section of Questionnaire 2 (Q2) part 16 called 
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use of OTC analgesics. There were 4 292 men and women that answered what type of OTC 
analgesic they have used during last four weeks (figure 1, flow chart).  
In Q1, the participants got questions concerning: health and diseases, use of health service 
and medicines, socio-demography, lifestyle and questions concerning women and 
pregnancy. 
In Q2 the participants are asked more detailed questions about use of OTC analgesics 
(appendix 3) as, a) type of OTC analgesics that are used and how often they are taken, 
within last four weeks, b) daily dose taken, c) reasons using the medicine, d) side effects, 
e) if they are combined with prescribed analgesics, f) questions on were OTC analgesics 
are bought, pharmacy, grocery, petrol station, internet or abroad. 
 
2.4 Flow Chart 
 





How often have you during the last              
4 weeks used OTC analgesics                            
n=12693  (missing 288)
Q2 n=12 440                            
Questionnaire item: Q2:16:1                
What type of OTC analgesic have you        
used (during last four weeks)? 
Paracetamol/ASA/ibuprofen/ 
naproxen/Phenazone with caffein     
Response n =4 292
Attended: n = 12 984 (66%)





Height and weight. BMI is defined as the body mass divided by the square of the body 
height (kg/m2), 
2.6 Variables:  
For a complete list of variables with response alternatives (appendix 4). 
2.6.1 Questionnaire1 (Q1)  
 Age per 31.12.2007 
 Sex (male, female) 
 How do you in general consider your own health to be? (very bad, good, neither good 
nor bad, bad, very bad) 
 How often have you during the last four weeks used the following medication? 
Painkillers non-prescription (not used the last four weeks, less than every week, every 
week but not daily, daily) 
 What is the highest level of education you have completed? (primary/secondary school, 
technical school/vocational school, high school diploma, collage university less than 4 
years, 4years or more) 
 Describe your exercise and physical exertion in leisure time (reading/watching TV/ 
other sedentary activity? Walking/cycling/other forms of exercise at least 4 hours a 
week? Participation in recreational sports/heavy gardening etc. at least 4 hours a week? 
Participation in recreational sports competition, regularly several times a week?). 
 How often do you usually drink alcohol? (never, monthly or less frequently,2-4 times a 
month, 2-3times a week, 4 or more times a week) 
 Do you/did you smoke daily? (yes now, yes previously, never) 
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2.6.2 Questionnaire 2 – section 16 (Q2; 16) 
 Which OTC analgesics have you used?  
paracetamol (not used, not every week, every week-but not daily, daily) 
acetyl salicylic acid (not used, not every week, every week-but not daily, daily) 
ibuprofen (not used, not every week, every week-but not daily, daily) 
naproxen (not used, not every week, every week-but not daily, daily) 
phenazone-caffeine (not used, not every week, every week-but not daily, daily) 
 What is your normal daily dose when taking paracetamol? (Number of tablets) 
 What is your normal daily dose when taking acetyl salicylic acid? (Number of tablets) 
 What is your normal daily dose when taking ibuprofen? (Number of tablets) 
 What is your normal daily dose when taking naproxen? (Number of tablets) 
 What is your normal daily dose when taking phenazone-caffeine? (Number of tablets) 
 What reasons do you have for taking non-prescription analgesics – headache? Yes, 
menstrual pain? Yes, migraine? Yes, backache? Yes, muscle ache/joint pains? Yes, 
tooth ache? Yes, other than headache, menstrual pain, migraine, backache, muscle 
ache/joint pains, tooth pain? Yes 
 Have you experienced side effects taking the OTC analgesics - paracetamol? Yes/No, 
acetyl salicylic acid? Yes/No, ibuprofen? Yes/No, naproxen? Yes/No, phenazone-
caffeine? Yes/No. 
 Where do you normally buy OTC analgesics – pharmacy? Yes, grocery? Yes, petrol 




2.7 Definitions of concept and expressions in the result 
The educational groups are formed from how many years studies that are expected for 
each group, primary or 1-2 years secondary school = “up to 9 years”, vocational or high 
secondary school (A-level) = “10-12 years” collage/university, = “more than 13 years”.  
Self-reported health: “bad”= bad and very bad, “good”= good and excellent. 
Activity: Exercise and physical exertion in leisure time.  
“Low activity” = reading watching TV, or other sedentary activity. “Walking /cycling >4 
hours/week” = Walking, cycling, or other forms of exercise at least 4 hours a week. “Sport 
activity/Hard training” = participation in recreational sport, heavy gardening etc. or 
participating in hard training and sport competition, several times a week.  
Use of alcohol: Table 7 and 9, “Never or seldom” = never or monthly or less frequently. “2-
4 times/month” is the same in the questionnaire. “Several times/week” = 2-3 times a 
week or four or more times a week.  
Daily smoking: yes/no, no = former smokers or not daily smokers. 
OTC analgesic use: “Seldom use” = use less than every week within last four weeks, 
“frequent use” = weekly or daily use within last four weeks. 
2.8 Wholesalers-based drug statistics, NIPH 
Norwegian Institute of Public Health and their wholesaler-based drug statistics was used 
to compare the use of OTC analgesics over time and study the changes in consumption 
since 2003 when the OTC analgesics were allowed to be sold in non-pharmacy outlets. 
The statistics includes sales of paracetamol, ibuprofen, naproxen, diclofenac, 
acetylsalicylic acid and phenazone-caffeine. The table gives sales figures on both Rx and 
OTC analgesics and shows sales from both the pharmacies and non-pharmacy outlets. 
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2.9 Statistical analysis 
Statistical analyses were conducted in IBM SPSS statistics 24. Statistical analyses were 
done with Pearson’s chi-square test, log linear analysis and logistic regression,  
2.10 Missing and inaccurate data 
The 288 participants in the study who did not answer the question about non-
prescription painkillers in Q1 was not included in the study. Those who also did not 
answer questions about health 0.7%, education 1.2%, activity 7.8%, alcohol 1.2%, 
smoking 1.3% and those without measurements to calculate BMI 0.3% were not included 
in those analysis. 
In the analysis of use of different OTC analgesics, all the participants who answered on 
one or more of  the question about which OTC analgesic they had used in the last four 
weeks was included, n = 4292 out of  the 5275 participants that gave a positive answer on 
the question about OTC- analgesics (non-prescription painkillers) in Questioner 1.  
Participants, who on the question about “amount of tablets used daily” did not answer or 
wrote zero tablets, were not included in the analysis.  
All original survey documents that included any extreme value of tablets used daily were 
controlled and corrected or not included in the analyses, if found incongruous. 
2.11 Systematic review of literature 
Systematic reviews of the literature in the field was carried out in the beginning of the 
study, in the middle of the study, and in the end of the study. Through Ovid Databases, 
EMBASE, MEDLINE, Cochrane library and PubMed, literature search was performed in 
January 2016, in April 2017 and in January 2018. Search was done to find articles 
concerning population studies in the field of Over-The-Counter, OTC analgesic, non-
prescription analgesics use and purchase of OTC analgesics focusing on Northern Europe 
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and the Nordic countries. Literature search was done in English and the Scandinavian 
languages. Some articles in German language was also browsed. Throughout the study 
period search has been done through Ovid databases at the university library, UiT and 
through google scholar search on the World Wide Web on use of OTC analgesics, purchase 
habits, efficiency, side effect, and user characteristics. Search has also been done 
concerning abuse and self-intended injury with OTC analgesics focusing on the 
Scandinavian countries. Literature and articles have also been given through people 
knowing the research field, including supervisor. Several articles have been found 
through other researches reference list. 
2.12 Ethical aspects  
The Regional Committee for Medical and Health Research Ethics of North Norway (REK 
Nord), and The Norwegian Data Protection Authority have approved the Tromsø study. 
The Tromsø study complies with the Declaration of Helsinki, International Ethical 
Guidelines for Biomedical Research Involving Human Subjects and the International 
Guidelines for Ethical Review of Epidemiological Studies. Participation was voluntary and 




 3. Results 
3.1 Sales of OTC analgesics in Norway. 
Table 1 shows sales statistics for OTC analgesics in Norway 2003-2016. From the year 
2003, OTC analgesics were also sold at non-pharmacy outlets. Table1 describes the sales 
of OTC analgesics (in DDD/1000 inhabitants/day) both in the pharmacies and in grocery 
stores, petrol stations etc. There are also information about sales of the prescription (Rx) 
analgesics and the total sales of each drug.  
In the period 2003-2016, the total sales of paracetamol (OTC+Rx) steadily increased from 
23.3 to 38.2 DDD/1000 inhabitants/day, an increase of 64.0 percent over these years. In 
2003, paracetamol was mostly sold as OTC, (73.4 %), however, this share was reduced to 
39.3 percent in 2016. Out of the total sale of OTC paracetamol 54.6 percent were sold at 
non-pharmacy outlets 2016.  
Ibuprofen increased steadily its total sales from 2003 to 2011 from 10.9 to 19.8 
DDD/1000inhabitants/day, (81.7 %). Since 2011, there has been a decrease in the sales 
with 3.0 DDD/1000 inhabitants /day, (15.2 %). Totally, in the period 2003 to 2016 the 
increase in the sales of ibuprofen was from 10.9 to 16.8 DDD/1000 inhabitants/day (54.1 
%). In 2016, 54.8 percent of the total sale of ibuprofen were sold as OTC analgesics. The 
share of OTC and Rx has been almost the same for ibuprofen over these 14 years. Out of 
the total sale of OTC ibuprofen 39.1 percent were sold at non-pharmacy outlets in 2016.  
Diclofenac increased steadily its sales from 2003 to 2011 from 5.3 to 11.4 DDD/1000 
inhabitants/day, (115 %). Since then, there has been a decrease in the sales with 4.2 
DDD/ 1000 inhabitants/day, (36.8 %). In the period 2003-2016 the increase in the total 
sales of diclofenac was from 5.3 to 7.2 DDD/1000 inhabitants /day, (35.8 %). 
Naproxen has almost the same sales in 2016 as it had in 2003.  
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The sales of acetylsalicylic acid as an analgesic drug has declined steadily from 2003-2016 
from 0.7 to 0.2 DDD/1000 inhabitants/day, (71.4%). Phenazone-caffeine has also 
declined steadily in the period from 3.6 to 1.4 DDD/1000 inhabitants/day, (61.1 %). Both 
ASA and phenazone caffeine are sold as OTC only in pharmacy. Phenazone-caffeine was 
sold in non-pharmacy outlets from 2003 to 2010. 
 
Table 1. Sales of OTC analgesics from the pharmacies and the non-pharmacy outlets in Norway 
2003-2016, DDD/1000 inhabitants/day.  
Source: The Norwegian Wholesaler-based drug statistics, Norwegian Institute of Public Health. 
 Year 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 
Paracetamol  
             
 
OTC Pharmacy 16.9 12.4 11.4 10.4 10.2 9.5 9.2 8.3 8.0 8.0 7.6 7.1 6.8 6.8 
OTC Grocery etc. 0.2 4.1 5.9 7.0 7.8 8.0 8.1 7.7 8.0 8.0 7.9 7.8 8.1 8.2 
Total OTC 17.1 16.6 17.3 17.4 18.0 17.5 17.3 16.0 16.0 16.0 15.5 14.9 14.9 15.0 
Total Rx 6.3 7.1 8.7 10.1 11.3 13.0 14.5 15.9 17.8 19.2 20.2 20.6 21.5 23.2 
Total DDD 23.3 23.6 26.0 27.5 29.3 30.5 31.8 31.9 33.8 35.2 35.7 35.5 36.4 38.2 
Ibuprofen  
             
 
OTC Pharmacy 5.8 5.0 5.3 5.5 6.1 6.6 6.6 6.3 6.8 6.4 6.1 5.8 5.6 5.6 
OTC Grocery etc.     0.1 2.0 2.8 3.3 3.7 4.0 4.1 4.1 4.2 4.1 3.7 3.5 3.7 3.6 
Total OTC 5.9 7.0 8.1 8.8 9.8 10.6 10.7 10.4 11.0 10.5 9.8 9.3 9.3 9.2 
Total Rx 5.1 5.7 5.9 6.4 7.0 7.6 8.1 8.2 8.8 8.6 7.9 7.9 7.7 7.6 
Total DDD 10.9 12.7 14.0 15.2 16.8 18.2 18.8 18.6 19.8 19.1 17.7 17.2 17.0 16.8 
Naproxen  
             
 
Total OTC 1.3 1.2 1.0 1.0 1.0 0.9 0.9 0.8 0.8 0.7 0.7 0.8 0.9 0.8 
Total Rx 3.5 3.1 3.6 3.5 3.4 3.3 3.3 3.1 3.2 3.2 3.1 3.3 3.5 3.6 
Total DDD 4.8 4.3 4.6 4.5 4.4 4.2 4.2 3.9 3.9 3.9 3.8 4.1 4.3 4.4 
Diclofenac  
             
 
Total OTC 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.5 0.6 1.2 0.7 0.8 0.7 
Total Rx 5.3 5.4 7.7 8.7 9.6 10.7 10.6 10.9 11.0 10.2 8.9 7.6 7.2 6.6 
Total DDD 5.3 5.4 7.7 8.7 9.6 10.9 11.0 11.4 11.4 10.8 10.1 8.3 8.0 7.2 
Acetylsalicylic acid  
            
 
Total DDD/OTC 0.7 0.6 0.5 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 
Phenazone-caffeine 
            
 
OTC pharmacy 3.5 3.1 2.8 2.5 2.4 2.3 2.0 1.8 2.0 1.9 1.8 1.7 1.5 1.4 
        OCT grocery etc.      0.0 0.4 0.5 0.4 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 





Figures based on numbers from Table 1: Sales of OTC analgesics in pharmacy and non-pharmacy outlets 
2003-2016  
 
Sales of paracetamol have 
increased with 64 %, 2003-
2016. OTC sales were 
reduced while the sales of 
Rx paracetamol have 
increased substantially. 
From 2003-2016 sales of 
ibuprofen increased from 
10.9-16.8 DDD/1000/day. 
In 2011, there was a top  
of 19.8 DDD/1000/day. 
About 40% of the OTC 
ibuprofen was sold in 
non-pharmacy outlets. 
Naproxen was mostly 
sold as a prescription 
drug. Only 18% was sold 
as OTC in pharmacy. ASA 
was only bought as OTC 
and the sales has declin-
ed. Phenazone-caffeine 
sales were reduced 2.5 
times within 14 years. 
Fig. 2: Sales of paracetamol (DDD/1000 inhabitants/day) 
in 2003-2016. Source: Wholesaler-based drug statistics, 
NIPH 
 
Figure 3: Sales of ibuprofen (DDD/1000 inhabitants/day) 
in 2003-2016. Source: Wholesaler-based drug statistics, 
NIPH  
 
Figure 4: Sales of naproxen, ASA and phenazone-caffeine, 
(DDD/1000 inhabitants/day) in 2003-2016. 


























































































































































































































































Figure 5: Sales of paracetamol, ibuprofen, naproxen, ASA, and phenazone-





Figure 6: Sales of paracetamol in Norway 2003-2016. 
Source: Wholesaler-based drug statistics, Norwegian Institute of Public Health, 
NIPH 
 
Diagrams in figure 5 and 6 are compiled from figures in Table1, page 22. 
Figure 5 gives the total amount of those drugs but are mostly influenced by 
the dominated sales trends of Paracetamol. The other drug sales (ibuprofen, 
naproxen, ASA and phenazone-caffeine) are illustrated separately in figure 3 
and 4. 
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3.2. Characteristics of the study population 
Table 2 shows that age is 
lower in the subpopulation 
compared to the total 
population of the study. 
There are also more 
women in the sub-
population compared to 
the total population. There 
are only small differences 
in education, health, 
activity and alcohol 
consumption between the 
groups. There are more 
smokers and more people 
with chronic pain in the 
subpopulation than in the 
total population. All are 
users of OTC analgesic in 
subpopulation compared 
with the total population 
where 41.6 % had used 
OTC analgesics within last 
four weeks. 
    Table 2. Characteristics of the study population.  






Age, years (means + SD) 57.5 (12.7) 54.1 (12.3) 
Age n                               30-39 
                                         40-49 
                                         50-59 
                                         60-69 
                                         70-79 













Sex                                  Women 






Up to 9 years 
10-12 years 









Self-reported health  
Bad  

















Sport activity >4 hours/week 






























                                   Yes now 
                                   Yes before  









BMI                               
                              Underweight 
                              Normal range 
                              Overweight 











Chronic Pain                  
                                         Yes 
                                         No   
Use of OTC analgesic    
                                         Yes 















3.3. Use of OTC analgesics 
Table 3 shows use of OTC analgesics within last four weeks according to sex, age, self-
reported health, level of education, physical activity, use of alcohol, smoking and BMI. 
The participants have answered how often they had used OTC analgesics within the last 
four weeks.  
 
There was a big sex difference in the use of OTC analgesics. The proportion of users 
were 52.0 and 29.7 percent in women and men respectively who had used OTC 
analgesics within the last 4 weeks, (OR gender 2.57, (95% CI 2.39-2.77)). An age 
adjustment with the figures from SSB Statistics Norway, 10-year age groups of 
Norwegian population 1of January 2008, gives higher figures. When we adjusted for age 
women use was 54.9 percent, men use of OTC analgesics was 33.6 percent.  
Younger people used more OTC analgesics than elderly people did. When we compared 
the youngest with the oldest age group, women had an OR of 2.41 (95% CI 2.09-2.78), 
while men had an OR of 2.84 (95% CI 2.37-3-41).  
Younger people mostly used OTC analgesics less than every week. 
Most of the OTC analgesics are used among those who have a bad self-reported health. 
When we compare those with bad health to those with excellent health, women had an 
OR of 2.60 (95% CI 2.04-3.30), while men had an OR of 2.96 (95% CI 2.20-3.99). It is 
even greater difference among the frequent users (weekly/daily use), when we compare 
those with bad to those with excellent health, for women OR=15.01 (95%CI 10.44-
21.59) men OR=10.42 (95%CI 5.97-18-21). There were 39.9 and 19.0 percent that 
consider their health as bad who, where using OTC analgesic weekly or daily in women 
and men, respectively. Out of women, 63.6 percent and 42.0 percent men with bad health 
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had used OTC analgesic within last 4 weeks. However, also some with excellent health 
had used OTC analgesics frequently (women 4.2 percent and men 2.2 percent). 
Those with less education used OTC analgesic more frequently compared to those with 
higher education. Women OR=1.59 (95% CI 1.35-1.87), Men OR=1.79 (95% CI 1.38-
2.32). 
Less OTC analgesics were used among those with high physical activity compared to 
those with low physical activity, women OR=0.81 (CI 95% 0.68-0.96) men OR=0.79 (CI 
95% 0.67-0.94), Frequent use: Women OR=0.47 (CI 95% 0.37-0.60) men OR=0.59 (CI 
95% 0.43-0.80). 
Those with some use of alcohol (2-4 times/month) used OTC analgesics mostly. There 
were more frequent use of OTC analgesics among those who did not use alcohol 
compared to those with high consumption, women OR=2.00 (CI 95% 1.34-2.96) men 
OR=2.36 (CI 95% 1.26-4.41). 
Daily smokers had used OTC analgesics last four weeks more than non-smoking people, 
women OR=1.35 (CI 95% 1.20-1.52), men OR=1.30 (CI 95% 1.14-1.50) also among the 
frequent users, women OR=1.73 (CI 95% 1.50-2.00), men OR=1.54(CI 95% 1.22-1.96). 
There was a higher percent of OTC analgesic users, among those who had a high BMI 
than in the group with normal range of BMI, women OR=1.27 (CI 95% 1.11-1.44), men 
OR=1.20 (CI 95% 1.02-1.41). Among women there are more users with frequent use 
(weekly/daily use) of OTC analgesic, in the group with high BMI, OR=1.67 (CI 95% 1.41-




Table 3. Use of OTC analgesics within the last 4 weeks, according to different characteristics. The Tromsø Study: Tromsø 6  
 
 
Women Men Women  Men  
  
    






Weekly or daily 
use 
(frequent use) 






Weekly or daily 
use 
(frequent use) 
       
  number number % OR (95% CI) % % OR (95% CI) % OR (95% CI) % % OR (95% CI) 
Sex            n=12693 
Women 6743 - 52.0 2.57 (2.39-2.77) 35.4 16.6 2.84 (2.51-3.20) - - - - - 
Men - 5950 - - - -  29.7 1.0 (reference) 23.1 6,6 1.0 (reference) 
Age adjusted 10 year age groups 1 Jan 2008*   54.9 - 38.2 16.8 - 33.6 - 27.3 6.3 - 
Total unadjusted Men and Women  41.6 - 29.6 11.9 - - - - - - 
Total age adjusted Men and women 45.3 - 33.3 12.0 - - - - - - 
Age             n=12693 
30-49 2194 1863 63.3 2.41 (2.09-2.78) 46.8 16.5 0.85 (0.71-1-02) 40.8 2.84(2.37-3.41) 33.2 7.6 1.22 (0.90-1.66) 
50-59 1267 1131 55.9 1.78 (1.52-2.08) 39.1 16.8 0.87 (0.71-1.07) 30.1 1.78(1.45-2.18) 24.1 6.0 0.94 (0.66-1.34) 
60-69 2054 1963 43.8 1.09 (0.95-1.26) 28.4 15.4 0.79 (0.65-0.95) 23.9 1.30(1.07-1-56) 17.9 6.0 0.94 (0.69-1.30) 
70-89 1228 993 41.7 1 (reference) 22.9 18.8 1 (reference) 19.5 1.0 (reference) 13.2 6.3 1.0 (reference) 
Self-reported health 








Bad 393 269 63.6 2.60 (2.04-3.30) 23.7 39.9 15.01(10.44-21.59) 42.0 2.96(2.20-3.99)  23.0 19.0 10.42(5.97-18.21) 
Neither good nor bad 1923 1655 59.6 2.19 (1.88-2.59) 32.0 27.6 8.59 (6.25-11.80) 34.9 2.19(1.79-2.68) 24.5 10.3 5.13 (3.14-8.41) 
Good 3329 3172 50.0 1.49 (1.29-1.71) 38.6 11.4 2.92 (2.12-4.02) 28.6 1.64(1.36-1.98) 23.9 4.7 2.18 (1.33-3.58) 
Excellent 1037 820 40.2 1 (reference) 36.0 4.2 1 (reference) 19.6 1 (reference) 17.4 2.2 1 (reference) 
Level of education 








Up to 9 years 2083 1453 47.4 0.81 (0.72-0.91) 28.5 18.9 1.59 (1.35-1.87) 28.4 0.94 (0.81-1.08) 19.7 8.7 1.79 (1.38-2.32) 
10-12 years 2133 2089 55.6 1.12 (1.00-1.26) 37.2 18.4 1.53 (1.30-1.80) 30.9 1.06 (0.93-1.20) 24.2 6.7 1.35 (1.05-1.74) 







Table 3. Use of OTC analgesics within the last 4 weeks, according to different characteristics. The Tromsø Study: Tromsø 6  
Continuous from last page 
 
 Women Men Women     Men     
  
    






Weekly or daily  
Use 
(frequent use) 






Weekly or daily  
Use 
(frequent use) 
 n n % OR (95% CI) % % OR (95% CI) % OR (95% CI) % % OR (95% CI) 
Activity 








Low activity 1214 1177 54.6 1 (reference) 32.5 22.2 1 (reference) 33.8 1 (reference) 25.3 8.5 1 (reference) 
Walking /cycling >4 h/week 4077 2897 53.0 0.94 (0.82-1.06) 37.2 15.8 0.66 (0.56-0.77 29.2 0.81 (0.70-0.93) 22.9 6.3 0.73 (0.56-0.94) 
Sport activity/Hard training  830 1512 49.3 0.81 (0.68-0.96) 37.5 11.8 0.47 (0.37-0.60) 28.8 0.79 (0.67-0.94) 23.6 5.2 0.59 (0.43-0.80) 







Never 929 444 45.1 0.62 (0.54-0.73) 24.7 20.5 2.00 (1.34-2.96) 26.8 0.79 (0.63-0.99 17.6 9.2 2.36 (1.26-4.41) 
< monthly 2053 1534 51.8 0.82 (0.73-0.92) 35.0 16.6 1.57 (1.08-2.30) 28.9 0.87 (0.76-1.01) 22.2 6.8 1.69 (0.95-2.99) 
2-4 times/month 2339 2468 56.8 1 (reference) 40.2 16.6 1.54 (1.05-2.25) 31.7 1 (reference) 25.6 6.1 1.49 (0.85-2.61) 
2-3 times/week 1023 1118 51.6 0.81 (0.70-0.94) 37.5 14.1 1.27 (0.85-1-90) 29.0 0.88 (0.75-1.03) 22.0 7.0 1.74 (0.97-3.12) 
> 4 times/week 289 339 42.2 0.56 (0.43-0.71) 30.8 11.4 1 (reference) 26.3 0.77 (0.59-0.99) 22.1 4.1 1 (reference) 







Smoking  1437 1133 58.0 1.35 (1.20-1.52) 34.9 23.0 1.73 (1.50-2.00) 34.3 1.30 (1.14-1.50) 25.4 8.9 1.54 (1.22-1.96) 
Non-smoking 5205 4756 50.5 1 (reference) 35.7 14.7 1 (reference) 28.6 1 (reference) 22.7 6.0 1 (reference) 
BMI               n=12651 
Underweight, < 18.5 63 18 42.9 0.74 (0.45-1.23) 27.0 15.9 1.16 (0.59-2.31) 38.9 1.67 (0.64-4.33) 22.2 16.7 3.04 (0.87-10.68) 
Normal range, 18.5 - < 25 2731 1670 50.3 1 (reference) 36.4 14.0 1 (reference) 27.6 1 (reference) 21.4 6.2 1 (reference) 
Overweight, 25- <30 2569 3033 52.0 1.07 (0.96-1.19) 34.9 17.1 1.28 (1.10-1.48) 30.1 1.13 (0.99-1.29) 23.9 6.1 0.99 (0.78-1.27) 
Obese, 30 and above 1354 1213 56.2 1.27 (1.11-1.44) 34.9 21.3 1.67 (1.41-1.97) 31.3 1.20 (1.02-1.41) 23.2 8.0 1.38 (1.00-1.78) 
* Norwegian population, figures from SSB Statistics Norway.
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3.4 Use of different OTC analgesics 
Table 4. There were 4292 participants who filled in Questionnaire 2 about analgesics, 
and they answered what type of analgesics and how often they had used OTC analgesics 
in the last four weeks. Out of this population, there was 52.2 percent who had used two 
or more OTC analgesics and 9.0 percent that had used three or more OTC analgesics. 
 
Paracetamol was the most used OTC analgesics, 86.5 percent use for women and 85.7 
percent use for men within the last four weeks. There is no statistical significant 
difference in use within the last four weeks between the age groups. However, women 
used paracetamol more frequently (weekly or daily use) than men in all age groups. 
Among women, 30.2 percent had used paracetamol weekly or daily, while among men it 
was 19.7 percent who used this drug frequently OR=1.77 (95% CI 1.52-2.06.)  In the 
elderly age group (70-89 years) they used paracetamol more frequently (weekly/daily 
use) than in the younger age group (30-49 years), women OR=2.34 (95% CI 1.83-2.99), 
men OR=1.62 (95% CI 1.06-2.50)  
 
Ibuprofen was used within the four weeks period by 57.2 percent women and 56.6 
percent men, no statistically gender difference OR=1.03(95% CI 0.91-1.17). Ibuprofen 
was used more, within the last four weeks, among young people (30-49 years) than 
among the elderly participants (70-89 years), women OR=5.42 (95% CI 4.20-7.01), men 
OR=3.68 (95% CI 2.51-5.39). Women used ibuprofen more frequently (weekly or daily 




Naproxen was mostly used among the women OR=1.45 (95% CI 1.08-1-93) compared to 
men, and especially among the younger women (30-49 years) OR=2.19 (95% CI 1.21-
3.97) compared to older women (70-89 years). The users of OTC-naproxen do not use it 
frequently, only 1.2 percent of the female and 0.8 of the male OTC analgesic users used 
naproxen weekly or daily.  
 
Men were using OTC-Acetylsalicylic acid almost two times more than women were in 
most of the age groups. Total use women OR=0.50 (95% CI 0.40-0.61) compared to men. 
The most frequent users are men 60-79 years old OR=1.86 (95% CI 1.27-2.74) 
compared to 30-49 years old men. 
 
Phenazone-caffeine was used by 3.7 percent men and 4.0 percent women within last 4 
weeks. Phenazone caffeine was used less frequently (weekly/daily) among the younger 
men OR= 0.12 (95% CI 0.03-0.57) and women OR=0.30 (95% CI 0.13-0.66) compared to 









Women  Men    
 
total n=4292 








Weekly or daily 
 Use 
(frequent use) 






Weekly or daily  
Use 
(frequent use) 
Paracetamol         n n % OR (95% CI) % % OR (95% CI) % OR (95% CI) % % OR (95% CI) 
30-49 1156 653 87.7 1 (reference) 62.3 25.4 1 (Reference) 89.0 1 (reference) 71.5 17.5 1 (reference) 
50-59 602 271 83.9 0.73(0.55-0.96) 56.3 27.6 1.12 (0.89-1.39) 84.9 0.70 (0.46-1.05) 67.2 17.7 1.02 (0.70-1.48) 
60-69 740 366 86.6 0.91(0.69-1.19) 53.6 33.0 1.44 (1.18-1.77) 81.9 0.56(0.39-0.81) 59.0 22.9 1.41 (1.03-1.93) 
70-89 363 141 86.8 0.92(0.65-1.30) 42.4 44.4 2.34 (1.83-2.99) 82.3 0.58 (0.35-0.96) 56.7 25.5 1.62 (1.06-2.50) 
Total 2861 1431 86.5 1.07(0.89-1.28)* 56.3 30.2 1.77(1.52-2.06)** 85.7 1 (ref. sex)* 66.0 19.7 1 (ref. sex)** 
Ibuprofen 








30-49 1156 653 70.8 5.42 (4.20-7.01) 51.6 19.1 1.86 (1.30-2.65) 66.9 3.68 (2.51-5.39) 54.7 12.3 1.27 (0.70-2-31) 
50-59 602 271 61.7 3.60 (2.73-4.75) 44.2 17.5 1.66 (1.13-2.44) 56.8 2.40 (1.57-3.65) 46.1 10.7 1.09 (0.56-2.13) 
60-69 740 366 45.5 1.87 (1.44-2.44) 32.3 13.2 1.20 (0.81-1.77) 45.9 1.54 (1.03-2.31) 35.8 10.1 1.02 (0.53-1.95) 
70-89 363 141 30.9 1 (reference) 19.6 11.3 1 (reference) 35.5 1 (reference) 25.5 9.9 1 (reference) 
Total 2861 1431 57,2 1.03(0.91-1.17)* 41.0 16.2 1.54(1.27-1.87)** 56.6 1 (ref. sex)* 45.4 11.2 1 (ref sex)** 
Naproxen 








30-49 1156 653 7.5 2.19 (1.21-3.97) 6.5 1.0 1 (reference) 4.3 0.97 (0.39-2.40) 3.9 0.4 1 (reference) 
50-59 602 271 6.3 1.81 (0.95-3.45) 5.8 0.5 0.48 (0.13-1.70) 5.9 1.41 (0.54-3.69) 4.8 1.1 1.46 (0.77-2.75) 
60-69 740 366 6.6 1.91 (1.02-3.57) 5.0 1.6 1.57 (0.70-3.52) 4.7 1.10 (0.42-2.84) 3.3 1.4 1.13 (0.61-2.10) 
70-89 363 141 3.6 1 (reference) 1.4 2.2 2.15 (0.87-5.30) 4.1 1 (reference) 3.5 0.7 1.03 (0.42-2-54) 










30-49 1156 653 4.5 1 (reference) 4.3 0.2 1 (reference) 9.3 1 (reference) 8.6 0.8 1 (reference) 
50-59 602 271 8.1 1.88 (1.26-2.81) 6.1 2.0 11.74(2.62-52.61) 12.2 1.35 (0.86-2.11) 11.1 1.1 1.45 (0.34-6.12) 
60-69 740 366 8.0 1.84 (1.25-2.70) 6.4 1.6 9.51 (2.12-42.62) 16.2 1.86 (1.27-2.74) 13.7 2.5 3.27 (1.09-9.82) 
70-89 363 141 6.1 1.37 (0.82-2.29) 4.7 1.4 8.06 (1.56-41.72) 14.9 1.70 (1.00-2.90) 11.3 3.5 4.77(1.36-16.68) 










30-49 1156 653 4.2 1 (reference) 3.4 0.8 0.30 (0.13-0.66) 3.4 1 (reference) 3.1 0.3 0.12(0.03-0.57) 
50-59 602 271 4.0 0.96 (0.58-1.58) 3.2 0.8 0.32 (0.12-0.86) 3.3 0.98 (0.45-2.17) 2.2 1.1 0.44 (0.12-1.66) 
60-69 740 366 4.4 1.08 (0.68-1.70) 1.9 2.5 1 (reference) 5.5 1.66 (0.89-3.08) 3.0 2.5 1 (reference) 
70-89 363 141 3.3 0.79 (0.42-1.50) 1.7 1.7 0.64 (0.25-1.61) 1.4 0.41 (0.10-1.78) 0.0 1.4 0.57 (0.12-2.68) 
Total 2861 1431 4.0 1.11(0.80-1.54)* 2.7 1.3 1.22(0.68-2.20)** 3.7 1 (ref. sex)* 2.6 1.1 1 (ref. sex)** 
 33 
 
3.5 Reasons for using different OTC analgesics 





All OTC analgesic Paracetamol Ibuprofen Naproxen ASA Phenazone 
Women Men Women Men Women Men Women Men Women Men Women Men 
n=2861 n=1431 n=2475 n=1227 n=1638 n=809 n=187 n=66 n=182 n=174 n=117 n=53 
n % n % n % n % n % n % n % n % n % n % n % n % 
Headache 1967 68.8 982 68.6 1718 69.4 859 70.0 1176 71.8 572 70.7 124 66.3 40 60.6 126 69.1 128 736 98 83.8 42 79.2 
Muscle/joint pain 1544 54.0 560 39.1 1355 54.7 482 39.3 941 57.4 358 44.3 131 70.1 43 65.2 104 57.1 71 408 63 53.8 20 37.7 
Bach ache 626 21.9 279 19.5 553 22.3 247 20.1 361 22.0 181 22.4 69 36.9 24 36.4 49 26.9 25 14.4 25 21.4 7 13.2 
Migraine 274 9.6 75 5.2 238 9.6 64 5.2 179 10.9 46 5.7 23 12.3 7 10.6 17 9.3 16 9.2 24 20.5 7 13.2 
Menstrual pain 344 12.0 - - 297 12.0 - - 260 15.9 - - 41 21.9 - - 18 9.9 - - 16 13.7 - - 
Tooth pain 159 5.6 96 6.7 141 5.2 82 6.7 114 7.0 64 7.9 12 6.4 3 4.5 11 6.0 9 5.2 9 7.7 4 7.5 
Other 239 8.4 135 9.4 213 8.6 116 9.5 116 7.1 61 7.5 11 5.9 6 9.1 32 17.6 13 7.5 10 8.5 3 5.7 
 
Table 5 shows the reasons for using different OTC analgesics. A person may have given several reasons for using of OTC analgesics.  
For all OTC analgesics, headache is the main reason for use, and muscle and joint pain was the second reason, and backache was reason 
number three. The table shows that OTC analgesics were used more due to muscle or joint pain among women (54.0%) than among men 
(39.1%),  OR=1.83(CI 95% 1.60-2.08). It shows also that OTC analgesics were used more due to migraine among women (9.6%) than 
among men (5.2%), OR=1.92(CI 95% 1.47-2.50).  Twelve percent of women used OTC analgesics related to menstrual pain. When 
studying the female naproxen users, 21.9 % of the users reported menstrual pain as reason for use.  
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3.6 Amount of tablets used daily of different OTC analgesics 
Table 6. Amount of tablets used daily of different OTC analgesics, mean, median, minimum and 
maximum compared with Defined Daily dose and use above DDD. The Tromsø Study: Tromsø 6 
Amount of tablets used daily of 
different OTC analgesics 
Valid 











Paracetamol 500 mg/tab 2865 2.23 2 1 12 6 (3.0) 15 0.5 
ASA 500  mg/tab 266 1.98 2 1 12 6 (3.0) 4 1.5 
Ibuprofen 200 mg/tab 1815 2.09 2 1 10 6 (1.2) 9 0.6 
Naproxen 250 mg/tab 222 2.20 2 1 6 2 (0.5) 65 29.7 
Phenazone-caffeine 500 mg/tab 130 1.95 2 1 6 6 (3.0) 0 0.0 
Table 6 shows the amount of tablets used daily of different OTC analgesics and compare 
this with DDD. The DDD is the assumed average maintenance dose per day for a drug used 
for its main indication in adults [25].  
Fifteen persons (0.5%) used paracetamol above DDD and three of them used 12 tabs per 
day, which corresponds to the double of the defined daily dose. One of the twelve used 
paracetamol daily. It was 77.6 percent of the OTC paracetamol users who reported taking 
1-2 tabs per day.  
For ibuprofen, the maximum amount was 10 tablets daily. In addition, nine persons used 
OTC ibuprofen above one DDD per day. It was 86.6 percent who reported use of 
ordinarily 1-2 tablets daily of ibuprofen. 
The DDD for OTC naproxen is two tabs (= 500 mg) and naproxen is used by more persons 
above DDD compared to the other OTC analgesics, where 29.7 % used OTC naproxen 
above one DDD per day. However, recommendations on the OTC package are up to three 
tabs per day. Thirty-one participants took three tablets, 27 took four tablets and seven 
persons took six tablets of OTC naproxen per day.  
Acetylsalicylic acid was used by four persons (1.5%) above DDD. The maximum amount 
of ASA tablets that anyone used daily was 12 tablets. Two subjects reported a dosage of 
12 tablets a day, i.e. the double amount of the defined daily dose.  
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It is not for sure that 500 mg tablets have been taken, 300 mg tablets was also available at 
the time. ASA 500 mg is the most common strength of ASA analgesic tablets in Norway at 
the time for the survey. In addition, one of them who reported 12 tablets/day has noted in 
the form that it is according to recommended dose from the physician.  
Those four persons who used ASA above DDD did not use ASA daily.  
Phenazone-caffeine was not used above the defined daily dose and 79.2 percent of the 
users reported use of 1-2 tabs per day.
 
3.7 Side effect of OTC analgesics
Table 7. Side effect of OTC analgesics 
The Tromsø Study: Tromsø 6 
n=4292 n % 
Paracetamol 102 2.4 
Ibuprofen 147 3.4 
Naproxen 118 2.7 
Acetyl salicylic acid 147 3.4 
Phenazone-caffeine 62 1.4 
 
 
Users of OTC analgesic report that they 
have experienced side effects. 
More people complain about side effects 
from ibuprofen and ASA than from other 
drugs. 
3.8 Use of OTC analgesics above Defined Daily Dose 
Table 8 shows the characteristics of the subjects that use OTC analgesic above the 
defined daily dose compared to those who reported use of one defined daily dose per day 
or less. This table is not analysed gender specific because the number of participants in 
each group is too low to get statistical significance. The percentage of users above one 
DDD per day is the same in the group of men and women. There is differences within age 
groups. Within the younger age group there are more who use OTC analgesics above DDD 
than in the older age group, OR=2.06 (CI 95% 1.04-4.10). Those with bad health report 
more doses above DDD, than those with good health, OR 2.42 (CI 95% 1.19-4.91).  
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There are more persons in the group of low physical activity that use more OTC analgesics 
than those who are more active. Anyhow, there is no statistical evidence on that (CI 95%), 
probably because the material we analyse is too small.  
It seems like the people that drink little or no alcohol and those with high consumption of 
alcohol use less OTC above DDD than those who drink alcohol 2-4 times/month. 
Those who smoked daily reported dosage of OTC analgesic above the DDD more often 
than the non-smokers did, OR=1.77 (CI 95% 1.12-2-79). Within the group of people with a 
higher BMI than 30(obese) there is also reported dosage of OTC analgesic above the DDD 
more often than among those with BMI between 25-30(over-weighted), OR=2.04 (CI 95% 
1.19-3.50). 
The participants that had bought OTC analgesic both in the pharmacies and in the non-
pharmacy outlets reported more often use of OTC analgesic above the DDD than those 
who only bought in pharmacy, OR=1.98 (CI 95% 1.25-3.13).  
There is a bigger share of participants in the group of frequent users (weekly/daily use), 
who use more OTC above one DDD per day. Even if it has not 95% CI, it give us an 
indication that it might be more common with more use above DDD among the frequent 




Table 8. Use of OTC analgesics above one DDD according to different characteristics. 
The Tromsø study: Tromsø 6  
  OTC analgesic 
use number 
Use above  1 DDD 
  % OR (CI 95%) 
Sex                                                                    n=3322 
 
  
Women 2249 2.6 1 (reference) 
Men 1073 2.6 (0.96 (0.64-1.60)) 
Age                                                                   n=3322 
 
  
30-44 1035 3.3 2.06 (1.04-4.10) 
45-64 1608 2.5 1.59 (0.81-3.11) 
65-89 679 1.6 1 (reference) 
 Self-reported health                                 n=3301 
 
  
Bad 220 4.5 2.42 (1.19-4.91) 
Neither bad or good 1083 3.4 1.80 (1.14-2.83) 
Good 1998 2.0 1 (reference) 
Level of education                                      n=3294 
 
  
Up to 9 years 827 2.1 0.60 (0.34-1.06) 
10-12 years  1177 3.4 1 (reference) 
More than 13 years 1290 2.2 0.63 (0.39-1.02) 
Activity in leisure time                              n=3140 
 
  
Low activity 655 3.1 1.25 (0.74-2.12) 
Walking /cycling >4 hours/w 1941 2.4 1 (reference) 
Sport activity / Hard training  544 2.6 1.05 (0.58-1.91) 
Use of alcohol                                               n=3291 
 
  
Never or seldom 1229 2.2 0.66 (0.41-1.07) 
2-4 times/month 1364 3.2 1 (reference) 
several times/week 698 1.9 0.56 (0.30-1.04) 
Smoking                                                         n=3289 
 
  
Non-smoking 2534 2.2 1 (reference) 
smoking 755 3.8 1.77 (1.12-2.79) 
Body Mass Index                                         n=3313 
 
  
BMI <25 1207 2.7 1.40 (0.83-2.34) 
BMI 25-30 1401 1.9 1 (reference) 
BM I >30 705 3.8 2.04 (1.19-3.50) 
Place of Purchase                                        n=3278 
 
  
The pharmacies 2173 2.0 1 (reference) 
Non-pharmacy outlets 292 3.1 1.54 (0.74-3.17) 
Both the pharmacies and non-pharmacy outlets 813 3.9 1.98 (1.25-3.13) 
Frequency of OTC analgesic use           n=3322                                                                                 
OTC analgesic use <every week 2318 2.2 1 (reference) 




3.9 Where do people buy OTC analgesics 
Table 9 describes the purchase habits of the OTC analgesic users according to sex, age, 
health, level of education, physical activity, alcohol consumption, smoking and BMI.  
There was totally 6.3 percent women and 15.8 percent men who bought OTC analgesics 
from non-pharmacy outlets only, while 70.0 percent women and 60.5 percent men bought 
OTC analgesics from the pharmacies only. We found that 23.7 percent women and 23.8 
percent men purchased OTC analgesics both places. 
Men purchased more OTC analgesics outside pharmacy compared to women OR=2.81  
(CI 95% 2.28-3.46), and younger people (30-44 years), buy more OTC analgesic from the 
non-pharmacy outlets compared to elderly (65-89 years), women OR=3.59 (CI 95% 2.07-
6.22), men OR=3.99(CI 95% 2.36-6.73). Older people (65-89 years), men and women, buy 
more OTC analgesics compared to younger people (30-44 years) from the pharmacies 
only, OR=5.32 (CI 95% 4.28-6.60).  
Persons with bad self-reported health, report buying in pharmacy only, more than 
persons with good health, women OR=1.48(CI 95% 1.05-2.10), men OR=1.86(CI 95% 
1.13-3.06).  Women with low education (up to 9 years), purchase more OTC analgesics 
from the pharmacies only compared to women with high education (more than 13 year), 
OR=1.73 (CI 95% 1.40-2.13). totally men and women OR=1.45 (CI 95% 1.23-1.72). We can 
see this trend among women but not among men. Higher educated women buy more OTC 
analgesics from non-pharmacy outlets compared to women with low education, 
OR=1.67(CI 95% 1.12-2.50).  
Women who smokes reported to purchase OTC analgesics from non-pharmacy outlets 
more often than the non-smokers OR=1.58 (CI 95% 1.31-1.90), also men seems to do that 
but it is not significant in this survey. 
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There are no statistically significant (95%) differences in purchase habits when we 
compared the different levels of physical activity. Use of alcohol does not either give any 
significant differences compared to those who do not use alcohol except that, those who 
use alcohol 2-4 times/months bought less OTC analgesic in pharmacy only than those 
who drinks alcohol several times a week among women OR= 0.76 (CI 95% 0.61-0.95). 
There are neither any significant differences when we see those with higher BMI 
compared to those with BMI in the normal range. 
There were 3826 out of 4224 persons (89.1 %) that reported to purchase OTC analgesic 
from the pharmacies, either from the pharmacies only, or in combination with purchases 
in the non-pharmacy outlet (23.7%). 
There were 398 persons, (9.4%) who reported to buy OTC analgesics from non-pharmacy 
outlets. Out of these persons 389 (97.7 %) reported grocery stores as place of purchase, 
three persons at petrol station and seven persons abroad. None purchased via the 
internet. 
Out of all OTC analgesic users, there was 1360 persons (31.7 %) that reported that they 
usually bought there analgesics in grocery shops. Most of the people (71.4 %) in this 
group have also usually bought OTC analgesics in other places.  
There were only 53 persons that report that they usually had bought OTC analgesics at 
petrol station only 1.2 % and only 55 persons 1.3 % reported that they usually bought 
OTC analgesic abroad. To purchase at internet seemed to be almost unknown in 2007-
2008, only two persons (0.05 %) has reported this, as the place where they usually 
bought OTC analgesics.  
One usual purchase place were reported by 75% of all OTC analgesic users, while 25 % of 
participants answered with two or more alternatives.
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Table 9. Characteristics of users according to place of purchase for OTC analgesics.  
The Tromsø Study: Tromsø 6 
 
Women  Men  Women  Men   
                             
  








de in pharmacy only 
 n n % OR (CI 95%) % % OR (CI 95%) % OR (CI 95%) % % OR (CI 95%) 
Age                               n=4224                                        
30-44 833 481 9.0 3.59 (2.07-6.22) 36.9 54.1 1 (reference) 22.9 3.99 (2.36-6.73) 30.4 46.8 1 (reference) 
45-64 1386 668 6.1 2.37 (1.38-4.08) 21.6 72.3 2.21(1.85-2.65) 14.1 2.20 (1.30-3.73) 23.4 62.6 1.90 (1.50-2.41) 
65-89 596 260 2.7 1 (reference) 10.4 86.9 5.62 (4.28-7.40) 6.9 1 (reference) 12.7 80.4 4.66 (3.27-6.65) 
 Total 2815 1409 6.3 1 (reference)* 23.7 70.0 1.53 (1.34-1.75)** 15.8 2.81 (2.28-3.46)* 23.8 60.5 1 (reference)** 
 Self-reported health 








Bad 187 84 3.7 1 (reference) 20.9 75.4 1.48 (1.05-2.10) 9.5 1 (reference) 17.9 72.6 1.86 (1.13-3.06) 
Neither bad or good 895 461 4.1 1.09 (0.50-2.39) 21.9 74.0 1.37 (1.15-1.64) 12.1 1.21 (0,58-2.55) 26.5 61.4 1.14 (0.88-1.40) 
Good 1709 860 7.7 2.11 (1.02-4.37) 25.2 67.2 1 (reference) 18.3 1.96 (0.96-3.99) 22.9 58.8 1 (reference) 
Level of education 








Up to 9 years 737 301 4.9 1 (reference) 17.9 77.2 1.73 (1.40-2.13) 14.3 1 (reference) 25.6 60.1 1.00 (0.75-1.32) 
10-12 years  958 517 5.9 1.28 (0.84-1.97) 25.2 68.9 1.13 (0.94-1.36) 14.7 1.05 (0.70-1.56) 24.4 60.9 1.03 (0.81-1.31) 
More than 13 years 1091 581 7.6 1.67 (1.12-2.50) 26.5 65.9 1 (reference) 17.6 1.29 (0.88-1.90) 22.5 59.9 1 (reference) 
Activity in leisure time 








Low activity 514 318 6.6 1.22 (0.73-2.04) 24.9 68.5 0.88 (0.67-1.15) 14.5 0.86 (0.58-1.29) 28.3 57.2 0.88 (0.65-1.18) 
Walking /cycling >4 hours/w 1791 664 6.4 1.17 (0.76-1.79) 23.5 70.1 0.65 (0.76-1.18) 16.0 0.97 (0.70-1.35) 22.0 62.0 1.07 (0.84-1.37) 
Sport activity / Hard training  332 364 5.7 1 (reference) 29.2 65.1 1 (reference) 16.5 1 (reference) 23.4 60.1 1 (reference) 






Table 9. Characteristics of users according to place of purchase for OTC analgesics.  
The Tromsø Study: Tromsø 6 
Continuous  from last page 
 
Women  Men  Women  Men   








de in pharmacy only 
Use of alcohol        n=4193 n n % OR (CI 95%) % % OR (CI 95%) % OR (CI 95%) % % OR (CI 95%) 
Never or seldom 1158 423 5.1 0.87 (0.56-1.34) 23.1 71.8 0.96 (0.77-1.20) 12.3 0.68 (0.45-1.01) 24.1 63.6 1.20 (0-90-1.60) 
2-4 times/month 1091 637 7.7 1.35 (0.89-2.04) 25.5 66.8 0.76 (0.61-0.95) 17.3 1.01 (0.71-1.42) 23.7 59.0 0.99(0.76-1.29) 
several times/week 539 345 6.1 1 (reference) 21.9 72.0 1 (reference) 17.4 1 (reference) 23.5 59.1 1 (reference) 
Smoking                              n4179 
Non-smoking 2124 1101 5.8 1 (reference) 21.7 72.5 1.40 (1.00-1.96) 15.0 1 (reference) 23.6 61.4 1.34 (0.96-1.86) 
smoking 655 299 7.9 1.58 (1.31-1.90) 29.5 62.6 1 (reference) 19.1 1.22 (0.94-1.58) 24.4 56.5 1 (reference) 
BMI 








(normal range) BMI<25 1145 379 7.0 1 (reference) 24.0 69.0 1 (reference) 15.3 1 (reference) 23.7 60.9 1 (reference) 
over weight BMI 25-30 1079 722 5.8 0.82 (0.58-1.15) 24.3 69.9 1.04 (0.87-1.25) 16.1 1.08 (0.77-1.52) 22.9 61.1 1.00 (0.78-1.29) 









4.1 Main findings from Tromsø 6 concerning use of OTC analgesics. 
1. There was a 45.3 % use of OTC analgesics among the population within last 4 weeks 
(54.9 % women and 33.6 % men). Most of the OTC analgesics were used seldom (less 
than every week) by 73.5 % of users, and was mostly used in a small daily dose, 1-2 tabs 
by 78.4 %.  
2. Paracetamol was the most used OTC analgesic, 86.3 %, and it was used more frequently 
among the elderly OR=1.60 (95% CI 1.40-1.84). Ibuprofen was used by 57 %, used more 
frequently by women OR= 1.54 (95% CI 1.27-1.87) and mostly used among young people. 
3. The main reasons for use of OTC analgesics was headache/migraine, 76.8 %, followed 
by muscle and joint pain 54 % and for backache by 21.9 % of the OTC users. 
4. Side effects from OTC analgesics were reported by users of paracetamol 2.4 %, 
ibuprofen 3.4 %, naproxen 2.7 %, ASA 3.4 % and phenazone-caffeine 1.4 %. 
5. There was 2.6 percent that used OTC analgesics above defined daily dose.  The people 
that bought OTC analgesic  both in the pharmacies and in non-pharmacy outlet reported 
dosage above the DDD more often than those who only bought OTC analgesic in pharmacy 
OR=1.98 (CI 95% 1.25-3.13).   Forty percent of OTC users, who used more than a Defined 
Daily Dose, used also OTC analgesic more frequently (daily/weekly use) than those who 
used a DDD or less per day.  
6. There was 70.0 percent women and 60.5 percent men who bought OTC analgesics from 
the pharmacies only, while 6.3 percent women and 15.8 percent men bought OTC 
analgesics from non-pharmacy outlets only. Younger people (30-44 years), buy more OTC 
analgesic from the non-pharmacy outlets compared to elderly (65-89 years), women OR=3.59 
(CI 95% 2.07-6.22), men OR=3.99(CI 95% 2.36-6.73). 
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4.2 Main findings from wholesaler-based drug statistics NIPH: (Table 1).  
The total sales (OTC+Rx) of paracetamol, ibuprofen, naproxen, diclofenac, ASA and 
phenazone-caffeine increased by 40 %, from the year 2003 to 2016. The OTC sales of 
analgesics decreased by 4.5 % in the same period. The sales of OTC analgesics outside 
pharmacy increased 2003 to 2009. Since then the sales of OTC analgesics outside 
pharmacy has been reduced by 6 %. The sales of Rx analgesics has doubled from 2003 to 
2016. It is Paracetamol and Ibuprofen that are dominating the sale of OTC analgesic drugs 
and has increased mostly during the period. Phenazone-caffeine and ASA has decreased 
its share of the sale. 
4.3 Comparison with other population studies 
1. From the study in Nord-Trønderlag (HUNT3, 2006-08) they got many results similar to 
the present study [10]. In their study use of OTC analgesics are 47% within last month 
compared with this study of 45 %, and among women 53 %, in this study 54.9 % use, men 
40 %, in this study 33.6 %. It is a bigger difference between sexes in the present study 
than what they have in The HUNT3 study. In the HUNT3 study as well as in present study 
the use of OTC paracetamol where not influenced by age. NSAIDs decreased while ASA 
increased in relation to age in HUNT3 as well as in Tromsø 6. In both studies, there are 
higher risk for using OTC analgesics if you have low or little physical activity especially 
among those with frequent use of OTC analgesic. Smoking increased the risk of using OTC 
analgesic in both studies. Use of alcohol, several times a week, reduce also the risk of 
using OTC analgesics frequently, in both studies. It might be that alcohol is a substitute for 
OTC analgesic or a self-medication related to pain as they also speculate in their report. 
Similar results, about alcohol used as self-medication related to pain, has been found and 
are discussed in other studies, [46,47,48]. 
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2. In a German study in 2008-2011 [5] OTC analgesic use was significant higher among 
women OR 1.71 and smokers OR 1,55, but lower among those aged 45 years and older, 
similar to present study. Those with more physical activity used significant less Rx 
analgesics OR 0.71. Ibuprofen was the most commonly used analgesic, followed by ASA, 
paracetamol, diclofenac and naproxen. 
3. In a Swedish study (1988-1989) the authors concluded that analgesics was used 50% 
higher among women than men [2]. This confirms the result of the present study that 
women use analgesics considerably more than men do. Overweight women used more 
analgesic then other women in Antonov’s study. In present study, both women and men 
with overweight use more OTC analgesic. Self-reported poor health explain also much the 
use of analgesic in the Swedish study. In that study from 1988-89 there are also a higher 
consumption of analgesic among smokers.  
4. In the Tromsø study 1986-87, (Tromsø 3), there was also twice as many users of 
analgesic among women compared to men [3]. People with low physical activity and daily 
smokers had also a high analgesic use. There was no age difference in analgesic use 
among people above 20 years. One fifth of the population used analgesics, women 28 % 
and men 13 %. It was headache, infection, backache, neck/shoulder ache that had the 
strongest association with analgesic use. Depression, sleeplessness and menstrual pain 
are also associated with higher use of analgesic. 
5. We compared this with the analgesic use in the same population study [9] 15 years 
later 2001-2002, (Women 53.7 % and men 29.1%). In 2007-2008, (Tromsø 6) the total 
analgesic drug use for women 59.6 % and men 36,7 %, all figures are age adjusted [9]. 
Also here more use among women then among men. (In this report the percentage of only 
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OTC users are presented, excluding those who also use Rx, this makes the figures different 
from ours even though we have the same material to study.)  
6. In Finland, the bestselling substance for pain management in 2002 was ibuprofen and 
paracetamol [49]. Fifty-four percent of ibuprofen was sold over the counter and that 
correspond very well to the present Norwegian figures. There was no significant 
difference in use of OTC analgesics in this study compared to sexes or age. Frequent 
analgesic use was more common in older age groups as well as in present study. OTC 
analgesic use were used mostly a few times a week rather than daily.  
7. A study from Scotland who was published 2005 showed a prevalence of 37 % of OTC 
analgesics use [4] within the last two weeks. This correspond with some of our findings. 
Being young, female and drinking alcohol where associated with OTC analgesics users in 
both studies. Headache, back pain and joint pain are the most common reasons for use of 
OTC analgesics in Scotland as well as in Norway. No significant association between 
smoking and OTC analgesic use in Scotland as it was in Norway. The most frequent used 
OTC analgesic in the Scottish survey is Paracetamol that is used almost twice as much as 
ibuprofen, which relates well to findings in Norway.  
8. In an Australian survey [11] conducted 2001 and 2009, 85 % in both surveys reported 
use of OTC analgesics at least once a year. Regular use (at least once a month) declined 
from 67.5 % in 2001 to 55 % in 2009. There was more female regular users 57 % in both 
surveys. OTC NSAIDS increased from 11-26 % from 2001-2009. In 2001, NSAIDs were not 
available outside the pharmacy setting but in 2009, 42.0 % of regular OTC NSAID users 
purchased this product in a general sales environment. More use of OTC analgesic among 
participants under 54 years and more use of NSAIDs than paracetamol among younger 
participants than those aged 55 years or more. 
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4.4 Characteristics of the users 
The characteristics associated with an OTC analgesics user were being young, female, bad 
health, drink alcohol moderately, daily smoker and have a high BMI.  
One reason that elderly people do not use as much OTC analgesics as younger does, are 
probably because they have those medicines on receipt from their physician [12]. 
We found that OTC ibuprofen was used almost twice as much in the youngest age group 
(30-49 years) compared to those above 70 years old. The reasons  is probably that 
ibuprofen is not recommended for the elderly without close follow up by a physician [23], 
[35,p1071], [33,p253], because of serious adverse effects (gastric ulcer, kidney damage, 
heart failure etc.).  
OTC naproxen is mostly used by young women. The only OTC indication is for menstrual 
pain, but we found that OTC naproxen were also used due to other reasons, i.e. middle 
aged men also reported use of naproxen. The reason why naproxen was reported used for 
other reasons than menstrual pain is probably that people know that naproxen can be 
used for other diagnoses. They may have got naproxen from their physician earlier for 
other reasons like muscle and joint pain.  
4.5 Purchase of OTC analgesic in pharmacies or in non-pharmacy outlets 
The important factors were sex, age, self-reported health, lifestyle and level of education. 
It seems that it is younger men, those with good health, high education and those who are 
smoking that buy more OTC analgesics at non-pharmacy outlets. Older people, women 
with low education and people who report bad health, inform that they use pharmacy 
more. It is fine, if our conclusions are correct, that those who are young have better health 
and have a higher education buy OTC analgesics outside pharmacy, and that those who 
are older and sick and need to ask somebody can do that in a pharmacy.  
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In a study from Sweden (2016) there was 76 % who had been to a pharmacy and 24 % 
that had bought drugs at non-pharmacy outlets last time they bought a drug [12]. In our 
study the question is formulated different, anyhow their result are comparable and 
confirm our results because the proportions are similar. The Swedish study showed that 
women, older people and those with lower education saw the availability of trained staff 
in the pharmacy as important. “Geographic proximity was reported as the overarching 
factor in the choice of retailer for any OTC drug.” Opening hours and available products 
were also seen as important.  
In a study from Australia they report from 2009 that 42 % of regular OTC NSAID users 
purchased this product in a general sales environment [11]. This is considerably higher 
than our figures for purchase at non-pharmacy outlets. 
4.6 Reasons for use of OTC analgesics 
The reasons for using OTC analgesics seemed to follow the OTC indications for use of the 
different drugs. The only exception is OTC naproxen, which was used for other reasons 
than menstrual pain, who is the only OTC indication.  One may think people know other 
indications for naproxen and how to use it. Maybe because they have got it prescribed 
from their GP earlier for minor health problems. It has gone a long time since the decision 
to have menstrual pain as the only indication for OTC naproxen. May be one should 




4.7 Use above DDD and over use.  
Those who reported to use more than one defined daily dose OTC analgesic daily were 
associated with being  young, consider own health as bad, has a medium long education, 
are not physical active, drink alcohol moderately, daily smoker and are obese. They were 
also associated with buying OTC analgesics at non-pharmacy outlets and taking OTC 
analgesics regularly.     
There were 2.6 % of the OTC users, who had taken more than one defined daily dose of 
OTC analgesics daily. Among OTC paracetamol users there is 14 persons (0.5%) who 
takes above one DDD daily.  We have nine persons (0.5%) in this material who takes more 
than one DDD daily of ibuprofen.  For ASA there is four persons (1.5%), who report use 
above one DDD daily. Phenazone-caffeine has no one reporting above one DDD daily.  
We found most users of more than one defined daily dose, daily among the OTC naproxen 
users. The defined daily dose for OTC naproxen is not based on the indication acute 
dysmenorrhea, but is based on the maintenance dose for the diagnosis rheumatoid 
arthritis. This may explain why so many users of OTC naproxen had used more than one 
DDD daily (65/222 OTC naproxen users, 29.3%). The recommended dosage found on the 
OTC naproxen package was up to three tablets (750 mg) daily (DDD=two tablets= 500 
mg). The Norwegian Pharmaceutical Product Compendium (Felleskatalogen) based on 
the approved SPC of the drugs, says that acute dysmenorrhea may be treated with as 
much as five tablets (1250 mg) daily.  
However, someone may have misunderstood the question and written a much higher 
number of tabs than what they actually did take. There might also be persons that use too 
much OTC analgesics that is not included because they did not show up in the survey. A 
survey of this kind is voluntary and those who are not so interested in health issues may 
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not show up. Other literature argue that “the vast majority do not take analgesic in 
overdose and that small minority who do suffer little or no sequel” [33,p255]. 
The Swedish medical products agency drew a conclusion from a comprehensive study in 
2015, that the majority of the public has a balanced view of OTC analgesic use and 
security,  and that the OTC analgesics are mostly used as intended [50]. 
4.8 Adverse effects  
Side effects from OTC analgesics were reported by users of paracetamol 2.4 %, ibuprofen 
3.4 %, naproxen 2.7 %, ASA 3.4 % and phenazone-caffeine 1.4 %. Users that experienced 
adverse effects may not necessarily have taken high doses of analgesics.  Jones stated that 
“Some analgesics have adverse effects in therapeutic doses and all analgesics are toxic in 
overdose”[33,p 245]. Paracetamol gives adverse effects in overdose while most of adverse 
effects occur in therapeutic NSAID doses. NSAIDs have lower incidence of severe features 
or death in overdose [33,p245]. Those who reported experience of adverse effect from 
different OTC analgesics in this report may have used those medicines earlier. It might not 
been used on the time for the survey. Approximately 0.02-0.04% of each countries 
population take paracetamol in overdose each year. A total of 0,02% of the Australian 
population and 0.08% of the UK population require admission or assessment at a health 
care facility each year because of paracetamol poisoning[33,p247].  
4.9 Overdose and intended poisoning with paracetamol 
The availability of paracetamol increases the risk of self-poisoning.” National policy 
decisions regarding restrictions on its availability need to weigh the inconvenience caused to 




The problem with paracetamol is self-poisoning. If it is too easy to get the drug, it might 
be a choice for someone in a desperate situation. Many knows that it is dangerous with a 
lot of paracetamol and that it can be fatal, but not all knows the consequences [43]. Many 
resources are used to rescue mostly young people that have tried to take their lives with a 
very bad poison for suicide. Most of patients are saved, but some gets liver damage and a 
few is in need of liver-transplantation after being treated for overdose [51]. It is common 
to use as self-poisoning among young girls and we know that availability, quantity and 
increase in sale increase the cases of self-poisoning [28,29,41]. One way to reduce the 
possibilities of these desperate actions is to make the availability to get a big amount of 
this medicine more difficult. One way is to reduce the package size, sell it only in 
pharmacies where there is trained staff and limited opening hours. Prescription of large 
boxes with medicine that is common to use for self-poisoning should be reduced and 
instead be sold in smaller package with blisters [33,p 253-254] . To sell OTC paracetamol 
tabs only in pharmacies was introduced in Sweden in November 2015 after an extensive 
investigation from the Medical product agency, Sweden [50]. The background is an 
increase in the number of poisoning cases in recent years where one can see a connection 
with the increased availability[52].  
4.10 Increased use of paracetamol and ibuprofen over time 
The total paracetamol sale increased by 63.9 percent between 2003 and 2016. It is due to 
increased prescription of these drugs and specially Rx paracetamol that increased 2.7 
times. Prescription of big packages caused the increase of total sale of paracetamol [30], 
The sales of OTC analgesics decreased with 4.5 percent in the period 2003-2016. One may 
speculate that this is caused by the huge difference in price between OTC and Rx 
paracetamol. It is a big difference in price, 5.5 times’ higher price for OTC paracetamol 
52 
 
compared to prescribed medicine in large package sizes. The increase of paracetamol has 
also to do with the recommendations from authorities to use paracetamol rather than 
NSAID because of side effects like bleeding/ stomach ulcers [53]. It is common to 
prescribe a unit of 1g x100tabs, which makes many people to have a unit with several 
paracetamol tablets at home. This may be a potential danger related to poisoning [41,43].   
The total sales of analgesics increased considerably in Norway over the last decades [9]. 
Since 1990 the sales, of ibuprofen has increased more than 6,5 times, and paracetamol 3 
times in DDD/inhabitants/day [26,p73, table]. There is concern that people are using OTC 
analgesics incorrectly or improperly and cause danger to their health [7,33,40,54]. We can 
see that we use more paracetamol and ibuprofen totally but the sale of OTC analgesics are 
almost the same over time. However, the fact that many people/families have many 
medicines at home may worry more. Even if it is not correct to share prescribed medicine 
some will do it instead of buying other medicine to family members, you share it 
especially if the price difference between Rx and OTC analgesics is large [55,56,57].   
 4.11 Strengths and weaknesses of the study 
The study has a big population with a relatively good participation. There might be a 
problem of selection bias even though there is an open invitation and a big population. It 
may be that those with more concern about their health and those who are more 
informed about health issues are more represented in the study. Those who are not so 
concerned or informed about the risks of overuse are probably less likely to participate in 
a voluntary population study. There may be an underrepresentation of people who use 
more OTC analgesics than they should do, because of a lack of interest to participate. It is 
also possible that people with more pain have been more willing to participate because of 
their concern in improvement of their health. That might be another confounder of the 
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result in the other direction. More women were participating in the study and women are 
using more OTC analgesics than men are, but most of the analysis was done with men and 
women separately.  There may be an underestimation of the use of OTC analgesics within 
this study because of recall bias, but this is probably minimal, because we are asking 
about the last four weeks, which is a relatively short recall period. Anyhow, this is 
probably the best way to get accurate figures because it is impossible to get direct 
registration from OTC analgesics. The statistics from NIPH and wholesalers data shows 
that use of OTC analgesics is almost the same today as it was in 2008. It is the Rx share 
that has increased of these analgesic drugs. This shows that the statistics can be 
representative for today even though the data from Tromsø 6 are 10 years old. The 
Tromsø population may be regarded as representative of a Northern European, urban 
population and it could be generalized to such a population [44]. Comparison with other 
studies in the Northern Europe shows similarities in the use of OTC analgesics. That 
shows that findings from this study can be applicable to similar populations in Northern 
Europe. 
4.12 Proposals on further studies 
The questions about adverse reactions in the specific Questionnaire about OTC analgesics 
(Q2:16) were not detailed enough to provide information about what kind of adverse 
reactions that might have occurred because of the use of a specific OTC analgesics. It 
would have been interesting to analyze what kind of ADR that might have occurred, not 
only that something occurred from a specific analgesic. There was a question, if people 




Studies should be done in the future on whether the use of OTC analgesics is increasing or 
not within the population. It would also be interesting to study if availability of 
paracetamol and ibuprofen in large Rx packages results in intentional poisoning among 
young adults. Material that has been gathered for more than 20 years, by social workers, 
at the University Hospital of Northern Norway, UNN about those who use drugs for self-
poisoning, could be used to investigate from where young adults get there paracetamol 
for self-poisoning, and suggest how interventions against this problem should be tackled. 
4.13 Suggestions and recommendations 
From this study, we can see that there are very little overuse and abuse of OTC analgesics 
among the general adult population. These analgesics should continue to be available 
Over-The-Counter and as far as possible in non-pharmacy outlets for the adult population. 
It is important for adults in need of analgesics, to be able to purchase them nearby. 
Geographic proximity, generous opening hours and a wide product range are important 
for ordinary consumers [12]. It is also recommended to discuss if e.g. naproxen, which is a 
very well known analgesic to treat muscle and joint pain, headache, backache and 
migraine, should be available OTC in pharmacies also for these indications. As it is today, 
it is only allowed to be sold Over-The-Counter to treat menstrual pain in Norway, but this 
is not followed according to results of present study.  
There is a problem with too easy access of paracetamol related to self-poisoning, specially 
within the younger population[29,58]. Therefore, it might also be advisable to sell 
paracetamol tablets only in pharmacies where staff is available to give advices. As it is in 
Norway today, it is easy to go into a shop at night and buy paracetamol and the limitation 
of 10 gram can easily be circumvented by going to several shops. It is an ethical dilemma 
if we allow this medicine to be available for the adult population even while at the same 
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time it cause huge health care costs, sufferings and death for youngsters with suicidal 
thoughts. The question is if it is the OTC sale at non-pharmacy-outlets or the Rx part of the 
sale that cause problems with self-poisoning. Initiatives to reduce the opportunities for 
people who are suicidal, to obtain mainly paracetamol in large quantities is advisable. 
This could be done with restrictive prescription of paracetamol in large quantities. It 
would also be better if paracetamol only were prescribed in blister packages and 
information given to users how to keep them safe at home.  
4.14 Conclusion 
The present cross sectional population study found that the majority of the adult OTC 
analgesic users follow the guidelines for use of OTC analgesics. Most of the OTC analgesics 
were used seldom and in a small daily dose. A small number of the participants report 
adverse effect from OTC analgesics. It is headache, muscle and joint pain and backache 
that is the main reasons for using OTC analgesics. The majority of the OTC analgesic users 
buy there OTC analgesics at the pharmacy. Very few purchased OTC analgesics on internet 
or abroad.  It seems that it is younger men, those with good health, high education and 
those who are smoking that buy more OTC analgesics at non-pharmacy outlets. Older 
people, women with low education and people who report bad health, inform that they 
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Tables and diagrams showing the Total sales of OTC analgesics   Appendix 1 
The same Diagrams as shown on page 24, figure 5 and 6, with detailed figures. 
Those tables are summarised from the figures in Table 1, page 22.  





2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Total DDD 43,2 44,7 48,3 50,6 53,7 55,9 57,6 56,9 59,9 60,3 59,2 58,7 59,5 61,1
Prescription 14,8 15,9 18,2 20,0 21,7 23,9 25,9 27,2 29,8 30,9 31,2 31,8 32,7 34,4
Total OTC 28,6 28,8 30,2 30,6 32,0 32,1 31,6 29,8 30,1 29,4 28,0 26,9 26,8 26,6
OTC Pharmacy 26,2 20,5 19,5 18,5 18,7 18,3 17,8 16,4 16,8 16,3 15,5 14,6 13,9 13,8



































Total sales of Paracetamol, ibuprofen, 
naproxen, ASA, Phenacone-caffeine
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Total DDD 23,3 23,6 26,0 27,5 29,3 30,5 31,8 31,9 33,8 35,2 35,7 35,5 36,4 38,2
Prescription 6,3 7,1 8,7 10,1 11,3 13,0 14,5 15,9 17,8 19,2 20,2 20,6 21,5 23,2
Total OTC 17,1 16,6 17,3 17,4 18,0 17,5 17,3 16,0 16,0 16,0 15,5 14,9 14,9 15,0
OTC Pharmacy 16,9 12,4 11,4 10,4 10,2 9,5 9,2 8,3 8,0 8,0 7,6 7,1 6,8 6,8









































Questionnaire 1, Tromsø 6         Appendix 2 
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Variable list for The Tromsø study: Tromsø study 6     Appendix 4 
 3 out of 12984 excluded from your selection, did not consent to medical research. 
GENERAL INFORMATION - GENERAL INFORMATION 
 YEAR_BORN_T6  - Birth year 
 MONTH_BORN_T6  - Birth month 
 AGE_T6  - Age per 31.12.2007 
 SEX_T6  - Sex 
  1 :  Male 
  0 :  Female 
 MARITAL_STATUS_T6  - Marital status 
  1 :  Single 
  2 :  Married 
  3 :  Widow/Widower 
  4 :  Divorced 
  5 :  Separated 
  6 :  Registered partnership 
  7 :  Separeted partnership 
  8 :  Divorced partnership 
 Q2_IMPORTED_T6  - Q2-imported 
  1 :  Yes 
 
PHYSICAL EXAMINATION - PHYSICAL EXAMINATION 
 HEIGHT_T6  - Body height in cm measured at screening 
 WEIGHT_T6  - Body weight in kg measured at screening 
 
HEALTH AND DISEASES - HEALTH AND DISEASES 
 HEALTH_T6  - How do you in general consider your own health to be? 
  5 :  Excellent 
  4 :  Good 
  3 :  Neither good nor bad 
  2 :  Bad 
  1 :  Very bad 
 HEALTH_COMPARED_T6  - How is your health now compared to others of your age? 
  5 :  Much better 
  4 :  A little better 
  3 :  About the same 
  2 :  A little worse 
  1 :  Much worse 
 MIGRAINE_T6  - Have you ever had, or do you still have migraine? 
  1 :  Yes 
  0 :  No 
 CHRONIC_PAIN_T6  - Do you have persistent or constantly recurring pain that has lasted for 3 months or 
more? 
  1 :  Yes 
  0 :  No 
  
USE OF HEALTH SERVICES - USE OF HEALTH SERVICES 
 CONSULTATION_GP_T6  - Have you during the past year visited a general practitioner (GP)? 
  1 :  Yes 
  0 :  No 
 CONSULTATION_GP_TIMES_T6  - If you have visited a general practitioner (GP) the past year, how many 
visits have you made? 
 
USE OF MEDICINE - USE OF MEDICINE 
 PAINKILLERS_PRESC_4WEEKS_T6  - How often have you used painkillers with prescription during the 
last 4 weeks? 
  1 :  Not used 
  2 :  Less frequently than every week 
  3 :  Every week, but not daily 
  4 :  Daily 
 PAINKILLERS_NOPRESC_4WEEKS_T6  - How often have you used painkillers without prescription during 
the last 4 weeks? 
  1 :  Not used 
  2 :  Less frequently than every week 
  3 :  Every week, but not daily 




FAMILY AND FRIENDS - FAMILY AND FRIENDS 
 LIVE_WITH_SPOUSE_T6  - Do you live with a spouse/partner? 
  1 :  Yes 
  0 :  No 
 
WORK, SOCIAL SECURITY PAYMENTS AND INCOME - WORK, SOCIAL 
SECURITY PAYMENTS AND INCOME 
 EDUCATION_T6  - What is the highest levels of education you have completed? 
  1 :  Primary/secondary school, modern secondary school 
  2 :  Technical school, vocational school, 1-2 years senior high school 
  3 :  High school diploma 
  4 :  College/university less than 4 years 
  5 :  College/university 4 years or more 
 OCCUPATION_FULLTIME_T6  - Is your main occupation/activity - full time work? 
  1 :  Yes 
 OCCUPATION_PARTTIME_T6  - Is your main occupation/activity - part time work? 
  1 :  Yes 
 OCCUPATION_UNEMPLOYED_T6  - Is your main occupation/activity - unemployed 
  1 :  Yes 
 OCCUPATION_HOUSEKEEPING_T6  - Is your main occupation/activity - housekeeping 
  1 :  Yes 
 OCCUPATION_RETIRED_T6  - Is your main occupation/activity - retired/benefit recipient ? 
  1 :  Yes 
 OCCUPATION_STUDENT_T6  - Is your main occupation/activity - student/military service? 
  1 :  Yes 
 HOUSEHOLD_INCOME_AVERAGE_T6  - What was the households total taxable income last year? 
Include income from work, social benefits and similar. 
  1 :  55 100 NOK 
  2 :  165 100 NOK 
  3 :  250 300 NOK 
  4 :  349 800 NOK 
  5 :  467 400 NOK 
  6 :  626 400 NOK 
  7 :  771 300 NOK 
  8 :  1 183 200 NOK 
 
PHYSICAL ACTIVITY - PHYSICAL ACTIVITY 
 PHYSICAL_ACTIVITY_WORK_T6  - If you have paid or unpaid work, which statement describes your work 
best? 
  1 :  Mostly sedentary work? (e.g. office work, mounting) 
  2 :  Work that requires a lot of walking? (e.g. shop assistant, light industrial work, teaching) 
  3 :  Work that requires a lot of walking and lifting? (e.g. postman, nursing, construction) 
  4 :  Heavy manual labour? (e.g. forestry, heavy farmwork, heavy construction) 
 PHYS_ACTIVITY_LEISURE_T6  - Exercise and physical exertion in leisure time. If your activity varies 
much, for example between summer and winter, then give an average. The question refer only to the last twelwe months. 
  1 :  Reading, watching TV, or other sedentary activity? 
  2 :  Walking, cycling, or other forms of exercise at least 4 hours a week? (including walking or 
cycling to place of work, Sunday-walking, etc.) 
  3 :  Participation in recreational sports, heavy gardening, etc.? (note: duration of activity at least 4 
hours a week). 
  4 :  Participation in hard training or sports competitions, regularly several times a week? 
 EXERCISE_T6  - How often do you exercise (i.e walking, skiing, swimming or training/sports)? 
  1 :  Never 
  2 :  Less than once a week 
  3 :  Once a week 
  4 :  2-3 times a week 
  5 :  Approximately every day 
 EXERCISE_LEVEL_T6  - If you exercise - how hard do you exercise? 
  1 :  Easy - you do not become shortwinded or sweaty 
  2 :  You become shortwinded and sweaty 
  3 :  Hard - you become exhausted 
 EXERCISE_DURATION_T6  - For how long time do you exercise? (give an average) 
  1 :  Less than 15 minutes 
  2 :  15-29 minutes 
  3 :  30-60 minutes 
  4 :  More than 1 hour 
                      2. 
 
ALCOHOL AND TOBACCO - ALCOHOL AND TOBACCO 
 ALCOHOL_FREQUENCY_T6  - How often do you usually drink alcohol? 
  1 :  Never 
  2 :  Monthly or less frequently 
  3 :  2-4 times a month 
  4 :  2-3 times a week 
  5 :  4 or more times a week 
 ALCOHOL_UNITS_T6  - How many units of alcohol (a beer, a glass of wine or a drink) do you usually drink 
when you drink alcohol? 
  1 :  1-2 
  2 :  3-4 
  3 :  5-6 
  4 :  7-9 
  5 :  10 or more 
 ALCOHOL_6UNITS_T6  - How often do you drink 6 units alcohol or more in one occasion? 
  1 :  Never 
  2 :  Less frequently than monthly 
  3 :  Monthly 
  4 :  Weekly 
  5 :  Daily or almost daily 
 SMOKE_DAILY_T6  - Do you/did you smoke daily? 
  1 :  Yes, now 
  2 :  Yes, previously 
  3 :  Never 
 
CONSUMPTION OF OTC ANALGESICS - Q2 - CONSUMPTION OF OTC 
ANALGESICS - Q2 
 PARACETAMOL_T6  - Which OTC analgesics have you used? - Paracetamol (Pamol, Panodil, Paracet, 
Paracetamol, Pinex)? 
  1 :  Not used 
  2 :  Not every week 
  3 :  Every week, but not daily 
  4 :  Daily 
 PARACETAMOL_DOSE_T6  - What is your normal daily dose when taking paracetamol? (Number of 
tablets, suppositories)? 
 ACETYL_SALICYLIC_ACID_T6  - Which OTC analgesics have you used? - Acetyl salicylic acid (Aspirin, 
Dispril, Globoid) 
  1 :  Not used 
  2 :  Not every week 
  3 :  Every week, but not daily 
  4 :  Daily 
 ACETYL_SALICYLIC_ACID_DOSE_T6  - What is your normal daily dose when taking acetyl salicylic 
acid? (Number of tablets) 
 IBUPROFEN_T6  - Which OTC analgesics have you used? - Ibuprofen (Ibumetin, Ibuprofen, Ibuprox, Ibux) 
  1 :  Not used 
  2 :  Not every week 
  3 :  Every week, but not daily 
  4 :  Daily 
 IBUPROFEN_DOSE_T6  - What is your normal daily dose when taking ibuprofen? (Number of tablets) 
 NAPROXEN_T6  - Which OTC analgesics have you used? - Naproxen (Ledox, Naproxen) 
  1 :  Not used 
  2 :  Not every week 
  3 :  Every week, but not daily 
  4 :  Daily 
 NAPROXEN_DOSE_T6  - What is your normal daily dose when taking naproxen? (Number of tablets) 
 PHENAZON_CAFFEINE_T6  - Which OTC analgesics have you used? - Phenazone-caffeine 
(Antineuralgica, Fanalgin, Fenazon-koffein, Fenazon-koffein sterke) 
  1 :  Not used 
  2 :  Not every week 
  3 :  Every week, but not daily 
  4 :  Daily 
 PHENAZON_CAFFEINE_DOSE_T6  - What is your normal daily dose when taking phenazone-caffeine? 
(Number of tablets)                    3. 
  
 
REASON_OTC_HEADACHE_T6  - Reason for taking OTC analgesics - Headache 
  1 :  Yes 
 REASON_OTC_MENS_PAINS_T6  - Reason for taking OTC analgesics - Menstrual pain 
  1 :  Yes 
 REASON_OTC_MIGRAINE_T6  - Reason for taking OTC analgesics - Migraine 
  1 :  Yes 
 REASON_OTC_BACK_ACHE_T6  - Reason for taking OTC analgesics - Back ache 
  1 :  Yes 
 REASON_OTC_MUSCLE_JOINT_T6  - Reason for taking OTC analgesics - Muscle ache/joint pains 
  1 :  Yes 
 REASON_OTC_TOOTH_PAIN_T6  - Reason for taking OTC analgesics - Tooth pain 
  1 :  Yes 
 REASON_OTC_OTHER_T6  - Reason for taking OTC analgesics - Others than Headache, Menstrual 
pains, Migraine, Back ache, Muscle ache/joint pains, Tooth pain 
  1 :  Yes 
 SIDE_EFFECTS_PARACETAMOL_T6  - Have you experienced side effects taking the OTC analgesics - 
Paracetamol? 
  1 :  Yes 
  0 :  No 
 SIDE_EFFECTS_ASPIRIN_T6  - Have you experienced side effects taking the OTC analgesics - Acetyl 
salicylic acid? 
  1 :  Yes 
  0 :  No 
 SIDE_EFFECTS_IBUPROFEN_T6  - Have you experienced side effects taking the OTC analgesics - 
Ibuprofen? 
  1 :  Yes 
  0 :  No 
 SIDE_EFFECTS_NAPROXEN_T6  - Have you experienced side effects taking the OTC analgesics - 
Naproxen ? 
  1 :  Yes 
  0 :  No 
 SIDE_EFFECT_PHENAZONE_CAFF_T6  - Have you experienced side effects taking the OTC analgesics - 
Phenazone-caffeine? 
  1 :  Yes 
  0 :  No 
 BUY_OTC_PHARMACY_T6  - Where do you normally buy OTC analgetics? Pharmacy 
  1 :  Yes 
 BUY_OTC_SUPERMARKET_T6  - Where do you normally buy OTC analgetics? Supermarket 
  1 :  Yes 
 BUY_OTC_PETROL_STATION_T6  - Where do you normally buy OTC analgetics? Petrol station 
  1 :  Yes 
 BUY_OTC_ABROAD_T6  - Where do you normally buy OTC analgetics? Abroad 
  1 :  Yes 
 BUY_OTC_INTERNET_T6  - Where do you normally buy OTC analgetics? Internet 
  1 :  Yes 
 COMBINE_OTC_RX_T6  - Do you combine OTC analgetics with Rx analgetics? 
  1 :  Yes 
  0 :  No 
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